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The major components of mitotic chromosomes including histones, 
topoisomerase II and condensin are known to compact and shape the chromatin into 
rod-like chromatids. However, a complete picture of the proteins involved in shaping 
mitotic chromatin is unsettled. 
Here, I perform mass spectrometry on chromatin isolated from Xenopus egg 
extracts. By comparing interphase and M phase, I reveal how the chromatin proteome is 
affected by the cell cycle. I find that although topoisomerase II associates with 
chromatin throughout the cell cycle, its catalytic activity is greatly enhanced in mitosis 
where it can act on nucleosomal substrates. In contrast, condensin is specifically 
recruited to M phase chromatin and prefers a non-nucleosomal substrate. I show that 
nearly all proteins involved in nucleosome assembly and remodeling are evicted from 
mitotic chromosomes, concurrent with a reduction in mitotic nucleosome assembly and 
discuss a role for these phenomena in shaping mitotic chromosomes. 
In analyzing my mass spectrometry data, I noticed that subunits of stoichiometric 
chromatin-bound complexes behaved similarly across a variety of conditions. Using this 
principle, I identify a novel nucleosome remodeling complex comprising HELLS and 
CDCA7, two proteins known to be causative for Immunodeficiency, centromeric region 
instability, facial anomalies (ICF) syndrome, a rare immunodeficiency disease. 
Consistent with previous literature, HELLS alone fails to remodel nucleosomes, but the 
HELLS-CDCA7 complex possesses robust nucleosome remodeling activity. CDCA7 is 
essential for loading HELLS onto chromatin, and CDCA7 harboring patient ICF 
mutations fails to recruit the complex to chromatin. Finally, I show that the HELLS-
CDCA7 complex is required for proper mitotic chromosome structure. Together, my 
study identifies a unique bipartite nucleosome remodeling complex where the functional 
remodeling activity is split between two proteins. 
These data lead me to a unifying model for ICF syndrome where all known ICF 
mutations converge on defective DNA methylation. I propose that HELLS-CDCA7 
mediated remodeling of juxtacentromere heterochromatic nucleosomes facilitates 
DNMT3B-mediated methylation and discuss this model alongside alternative models for 
ICF syndrome. Finally, I consider the role of CDCA7 paralogs in differentially regulating 
HELLS, and present an outlook on the future of ICF syndrome research.
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CHAPTER 1: INTRODUCTION 
The cell cycle 
The cell cycle 
For a cell to become two cells, it must duplicate and segregate its entire genome. 
These two process are temporally separated into interphase (the growth and duplication 
phase) and mitosis (the division phase) and repeat in turn for every cellular division. In 
interphase cells duplicate their cellular contents including their DNA and other 
organelles. Once duplicated in constitution, in mitosis the cellular components are 
divided in two, each daughter receiving an entire copy of genomic DNA and organelles 
(detailed below). This coordinated progression results in two cells, each with an entire 
genomic set, and the cycle can start over. Since the original discovery of genetic factors 
involved in the regulation of the cell cycle(Hartwell et al., 1970), many of the molecular 
details have been elucidated. 
Mitosis 
Mitosis is the phase of the cell cycle where the duplicated genome is split into 
two separate cells (reviewed in (Morgan, 2007)). The main driver of all aspects of 
mitosis is the protein kinase  Cyclin Dependent Kinase (Cdk1)(Coudreuse and Nurse, 
2010). Activated by mitotic expression of cyclin B(Jeffrey et al., 1995; Murray and 
Kirschner, 1989; Murray et al., 1989), Cdk1-cyclin B initiates and controls all 
downstream mitotic stages. Prophase, the first visible stage of mitosis, is where 
chromosomes condensation and individualization begins.  Nuclear envelope breakdown 
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occurs and the machinery to segregate the chromosomes assembles on chromatin 
during prometaphase. At metaphase, chromosomes are attached to microtubules and 
aligned at the metaphase plate.  Individual chromosomes can easily be visualized, with 
identically replicated sister chromatids held together with cohesin. Once chromosomes 
are aligned at the metaphase plate, cohesin(Ciosk et al., 1998) and cyclin B(Irniger et 
al., 1995; Murray et al., 1989) are degraded, leading to Cdk1 inactivation, sister 
chromatid segregation, chromosome decondensation, nuclear envelope formation, and 
the beginning of the next cell cycle. 
In addition to Cdk1, a variety of other mitotic kinases facilitate proper 
chromosome segregation. Aurora B, the kinase component of the chromosome 
passenger complex (CPC), phosphorylates numerous substrates, performing many 
mitotic functions, which include mitotic spindle assembly and ensuring that 
chromosomes are properly oriented in the spindle (Carmena et al., 2012). The CPC is 
recruited to mitotic chromosomes by the mitotic phosphorylation of threonine 3 on 
histone H3, which is phosphorylated by haspin(Kelly et al., 2010; Wang et al., 2010; 
Yamagishi et al., 2010). Specifically, the CPC subunit survivin recognizes H3T3ph to 
localize and active the complex.  Polo like kinase (Plk1) is required to release cohesin, 
the molecule responsible for linking together replicated sister chromatids, from 
chromosome arms during prophase(Sumara et al., 2002). These kinases are 
specifically activated in mitosis, downstream of Cdk1, to coordinate mitotic events. 
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Chromatin throughout the cell cycle 
Chromatin, the nucleic acid-protein complex comprising the cellular genetic 
material, undergoes dramatic morphological changes throughout the cell cycle. In 
interphase, chromatin is loosely packaged into the nucleus (reviewed in (Dixon et al., 
2016)). This “open” chromatin state is important for DNA based transactions including 
transcription, replication, and DNA damage repair. Although, densely packaged 
heterochromatin is inherently refractory to DNA based processes including 
transcription(Lorentz et al., 1992), DNA repair(Cowell et al., 2007), and DNA 
methylation(Lyons and Zilberman, 2017), the cell has specialized mechanisms to 
overcome these barriers. 
How chromatin is organized in the genome has been a topic of intense study. 
Recently, the technique Hi-C has been developed to probe the local and long range 
interactions between genomic loci(Lieberman-Aiden et al., 2009). In Hi-C, the genome 
is fixed and digested with nucleases. Following digestion, the genome is re-ligated and 
sequenced. DNA that has re-ligated with new sequences in the genome is indicative of 
a spatial interaction between the two loci. This technique has yielded immense insight 
into the organization of interphase chromatin. Most importantly, the genome is 
organized into megabase-sized topological domains in which DNA preferentially 
interacts with other DNA in the domain and not with DNA outside of the domain(Dixon et 
al., 2012). Genes within topological domains tend to be transcriptionally co-regulated(Le 
Dily et al., 2014), and disruption of topological domains results in strong transcriptional 
defects. Furthermore, the topological domains are compartmentalized into “active” and 
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“repressed” regions, termed A/B compartments, which correlates with their gene 
expression(Lieberman-Aiden et al., 2009). 
As opposed to interphase, mitotic chromosomes reproducibly individualize into 
discrete chromosomes, and can often be seen as compact rod-like sturctures. 
Compaction of chromosomes begins in prophase(Nagasaka et al., 2016), and continues 
through metaphase when condensed chromosomes are aligned on the metaphase 
plate. As sister chromatids are pulled apart, chromosomes arms axially compact further 
in anaphase to prevent segregation errors, in an Aurora B dependent manner(Mora-
Bermudez et al., 2007). Interestingly, mitotic chromosome structure is consistent across 
a variety of tested cell types(Naumova et al., 2013), whereas the compartmentalization 
of interphase chromatin is highly cell type dependent. Since mutants affecting the 
compaction of chromosomes result in non-individualized, catenated chromosomes, the 
main role of mitotic chromosome condensation is to facilitate decatenation and 
ultimately separation of sister chromatids(Nasmyth, 2001).  Additionally, chromosomal 
compaction is required to accommodate the spatial constraints of mitosis(Schubert and 
Oud, 1997). Although mitotic chromatin is highly condensed, experiments surprisingly 
showed that pentameric GFP molecules can diffuse freely through mitotic chromatin, 
suggesting that the dense chromatin is still accessible through diffusion(Nozaki et al., 
2013). The molecular determinants of mitotic chromosome structure are detailed below. 
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Chromatin 
The nucleosome 
The fundamental unit of packaging DNA into the interphase nucleus and mitotic 
chromosomes is the nucleosome. Eight core histones, comprising a tetramer of (H3-
H4)2 and two H2A-H2B dimers, are wrapped in ~147 base pairs of DNA and form a 
nucleosomal monomer(Luger et al., 1997). The nucleosome is assembled in a step-
wise fashion (Smith and Stillman, 1991) where DNA first wraps an H3-H4 tetramer, 
forming a stable intermediate. Consistent with the H3-H4 tetramer embedded within the 
nucleosome, there is very little turnover of H3-H4 on cellular chromatin measured by 
FRAP on GFP-H3 and GFP-H4(Kimura and Cook, 2001). This implies that even during 
active processes like transcription, the H3-H4 core tetramer is very stable. Following 
tetrasome formation, H2A-H2B dimers are incorporated externally to the H3-H4 
tetramer within the core particle. In contrast to H3-H4 the surface of the nucleosome is 
actively exchanged; nearly 40% of chromatinized H2A-H2B is turned over within hours 
in cells(Kimura and Cook, 2001). Much of this turnover depends on transcription 
suggesting that processes that require access to DNA can result in the eviction of H2A-
H2B dimers. 
In addition to core histones (H3, H4, H2A, H2B), nucleosomes contain lysine-rich 
histones, termed linker histones, that associate with the peripheral surface of the 
nucleosome particle. However, not every cellular nucleosome is associated with a linker 
histone. The stoichiometry of linker histones to nucleosomes varies between cell types 
and organisms, but linker histone occupancy ranges from 60-100%(Van Holde, 1989). 
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H1, the most well studied linker histone, was shown to dock on the nucleosome dyad by 
cryo-EM, interacting with core DNA and linker DNA simultaneously(Bednar et al., 2017). 
Through interacting with flanking DNA entering and exiting the nucleosome, H1 
constrains the dynamics of DNA linking adjacent nucleosomes, which is hypothesized to 
compact nucleosomal arrays. Many in vitro studies have led to the hypothesis that H1 
compacts nucleosomal arrays into a precise repetitive structure termed the 30-nm 
fiber(Chen and Li, 2017), including in a recent cryo-EM structure(Song et al., 2014). 
Unfortunately, there is little evidence for the 30-nm fiber in vivo(Eltsov et al., 2008; 
Nishino et al., 2012), suggesting that the 30-nm fiber may be an in vitro artifact that can 
only form under precise conditions or in specialized contexts such as chicken 
erythrocytes(Langmore and Schutt, 1980) and starfish sperm(Woodcock, 1994). 
Regardless of the specific structure, the constraints that H1 imposes on linking DNA is 
predicted to have a direct consequence on arrays of nucleosomes. 
Forming a mitotic chromosome: Histones 
As nucleosomes are the fundamental underlying unit of mitotic chromatin, they 
were assumed to be a prerequisite for mitotic chromosome structure, however, 
accessing the role of histones in vivo is technically difficult. Each core histone is present 
in multiple non-allelic copies in the genome, and in some species up to hundreds of 
repeats (reviewed in (Van Holde, 1989)), which makes traditional genetic manipulation 
difficult. Nevertheless, a recently study showed that mitotic chromosomes can still form 
in the absence of core histones. Using Xenopus egg extracts, which can assemble 
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mitotic chromosomes from exogenous DNA substrates, it was shown that histone-free 
rod-like mitotic chromosomes can form in extracts depleted of HIRA(Shintomi et al., 
2017), a factor required to load H3-H4 onto chromatin(Ray-Gallet et al., 2007). The 
mitotic chromosomes retained their three-dimensional structure but were less 
condensed, suggesting that the role of histones is to compact DNA locally but not 
dictate the global structure of the mitotic chromosome. This finding is consistent with 
historic data showing that the central axis metaphase chromosomes can be retained 
even after washing off histones (Paulson and Laemmli, 1977). 
Linker histones possess similar technical challenges as core histones. Humans 
possess at least ten H1 variants, with most somatic cells expressing approximately six 
different variants(Van Holde, 1989). Although each H1 variant is typically only located 
once in the genome, combinatorial deletion of multiple H1 variants is lethal, and H1 
variants have overlapping functions(Fan et al., 2003). Because of these challenges, the 
role of H1 in shaping mitotic chromosomes is conveniently studied in Xenopus egg 
extracts, as there is a single H1 variant present in the maternal egg(Dworkin-Rastl et al., 
1994) which can be immunodepleted from the extract(Dimitrov et al., 1994). Assembly 
of mitotic chromosomes in H1 depleted Xenopus egg extract results in rod-like mitotic 
chromosomes that are mostly normal(Maresca et al., 2005). However, one pronounced 
defect is that H1 depleted chromosomes are axially elongated and radially thinner than 
wildtype mitotic chromosomes. H1 depleted chromosomes appear fragile and unable to 
resist forces from microtubules causing them to appear “stringy” in the mitotic spindle 
(Maresca et al., 2005). It is hypothesized that H1’s effect on chromosome compaction is 
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direct because no other major chromosomal proteins are affect after H1 depletion; 
however, the contribution of minor proteins cannot be excluded. This is consistent with 
in vitro studies showing that H1 has a direct effect on the structure of 
chromatin(Fyodorov et al., 2017). 
Forming a mitotic chromosome: Non-histone proteins 
Since depletion of core histones only prevents compaction but does not prevent 
the shaping of mitotic chromosomes(Shintomi et al., 2017), there must be other factors 
involved in this process. After core histones and H1, the most abundant protein 
components of mitotic chromosomes are condensins and topoisomerase II(Hirano and 
Mitchison, 1994; Saitoh et al., 1994), which play important roles in shaping mitotic 
chromosomes, discussed below and summarized in Figure 1-1. 
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Figure 1-1. Factors influencing the compaction and shaping of mitotic 
chromosomes. Shown is a schematic depiction of wildtype mitotic chromosomes 
(center) that form stereotypical compact rod-like chromatids. Depletion of core histones 
(left) still maintains rod-like structure, however, the DNA is decompacted. To shape 
mitotic chromosomes, condensin I and KIF4 are required for lateral compaction of 
mitotic chromosomes (bottom right) while topoisomerase II, condensin II, and H1 are 
required for axial compaction of mitotic chromosomes. 
Topo II
Condensin II
H1
Condensin I
KIF4
Core
histones
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Topoisomerase II is an ATP-dependent enzyme which transiently creates a 
double strand break in a DNA molecule to allow the passage of a second strand of DNA 
through the break(Berger et al., 1996). This activity is important in the untangling of 
DNA for proper resolution of sister chromatids during chromosome 
segregation(Nagasaka et al., 2016). Although the mechanism remains unclear, 
topoisomerase II localizes to the central axis of mitotic chromosomes and is required for 
mitotic chromosome formation in Xenopus egg extract(Cuvier and Hirano, 2003). 
Specifically, it appears that topoisomerase II depleted chromosomes become axially 
elongated(Sakaguchi and Kikuchi, 2004; Samejima et al., 2012). It was originally 
thought that topoisomerase II formed a requisite scaffold for mitotic chromosome 
structure, however it was shown that topoisomerase II could be washed off of 
chromosomes without majorly affecting the chromatid rod-like structure(Hirano and 
Mitchison, 1993). 
Condensin is a five subunit complex which can supercoil DNA in an ATP 
dependent manner(Kimura and Hirano, 1997). Similar to topoisomerase II, condensin 
localizes to the chromatid central axis and is required for mitotic chromosome formation 
in Xenopus egg extract(Hirano and Mitchison, 1994). The ATPase activity of condensin 
is required for this process, suggesting that the supercoiling activity of condensin is 
important in this process(Kinoshita et al., 2015). There are two condensin complexes 
(condensin I and II); the exact defect of condensin depletion on chromosome structure 
depends on the specific condensin complex(Green et al., 2012). Depleting condensin I, 
comprising SMC2, SMC4, CAPG, CAPH, and CAPD2, results in laterally decompact 
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chromosomes. Depleting condensin II, comprising SMC2, SMC4, CAPG2, CAPH2, and 
CAPD3, results in axially decompact chromosomes which are reminiscent of 
topoisomerase II and H1 depletion. Interestingly, there may be interplay between 
condensin and topoisomerase II where positive supercoiling by condensin facilitates 
active decatenation by topoisomerase II(Baxter et al., 2011; Cuvier and Hirano, 2003). 
Finally, another protein located at the chromosome central axis, KIF4, has been shown 
to be required for the lateral compaction of mitotic chromosomes(Mazumdar et al., 
2004; Samejima et al., 2012), similar to condensin I. 
Drawing from these experiments, it was recently shown that mitotic chromatid 
formation from sperm chromatin could be reconstituted from purified components using 
only core histones, histone chaperones (nucleoplasmin, Nap1 and FACT), 
topoisomerase II and condensin, indicating that these are the minimum set of factors 
involved in mitotic chromosome formation(Shintomi et al., 2015). 
It is likely that axial and lateral compaction of mitotic chromosomes are 
competing activities, where axial compaction prevents excess lateral compaction and 
vice versa(Samejima et al., 2012). Accordingly, KIF4 depleted lateral chromosome 
elongation can be rescued by double depletion of KIF4 (a lateral compacter) and 
topoisomerase II (an axial compacter). This raises the question of whether axially 
elongated H1 or topoisomerase II depleted chromosomes are inherently defects of 
under-compaction or over-compaction; H1 or topoisomerase II depletion could directly 
increase lateral compaction resulting in axial elongation or alternatively could directly 
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decrease axial elongation that results in lateral compaction. As their mechanism of 
compaction is unknown, either hypothesis is possible. 
There is a major gap in understanding how the biochemical properties of 
topoisomerase II (DNA decatenation) and condensin (ATP dependent DNA 
supercoiling) lead to properly shaped mitotic chromosomes. The proteinaceous central 
axis of mitotic chromosomes is thought to be a key determinant of mitotic chromosome 
structure. In a widely accepted, but not well studied model, mitotic chromosomes are 
thought to be composed of DNA loops, where the anchor of loops are positioned at the 
chromatid axis. This arrangement was first visualized by electron microscopy on histone 
extracted HeLa chromosomes, which indicated that the axis-loop structure did not 
require histones(Paulson and Laemmli, 1977). In a landmark study, spatial contact data 
from Hi-C experiments was used to show that mitotic chromosomes form a 
homogenous structure that is not dictated by the DNA sequence(Naumova et al., 2013). 
Indeed, data from this study were consistent with the previously proposed DNA looping 
model and estimated the loop size to be 80-120kb. A key insight from this study was 
that loop anchors are randomly positioned between cells, reconciling the inability to 
identify loop anchoring DNA sequences or motifs. Strikingly, mitotic loop formation 
depends entirely on condensin in fission yeast and condensin depletion results in mitotic 
chromatin that essentially resembles interphase chromatin in Hi-C(Kakui et al., 2017), 
indicating that condensin is a key driver of this process. 
But how does condensin form mitotic loops? At present, only untested theoretical 
models exist. However, in a recent single molecule study(Eeftens et al., 2017), it was 
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shown that condensin can bind DNA in the absence of ATP but can only topologically 
entrap DNA following ATP hydrolysis. After entrapment, condensin can compact DNA 
against force. Most importantly, condensin was shown to be a motor that can walk along 
DNA(Terakawa et al., 2017). In addition to its motor activity, it can bind a separate 
strand of DNA while walking. These activities have been shown to theoretically be 
sufficient for loop formation and chromosome compaction(Goloborodko et al., 2016), 
further supporting the notion that condensin mediated loops may facilitate mitotic 
chromosome shaping. 
Nucleosome Remodeling Complexes 
Nucleosome remodeling 
DNA is packaged into nucleosomes to facilitate packing into the nucleus or 
mitotic chromosomes, but nucleosomes are refractory to a variety of processes that 
must use the DNA within. In interphase, nucleosomes prevent transcription factor 
binding(Adams and Workman, 1995), RNA synthesis(Teves et al., 2014), DNA 
replication(Gasser et al., 1996), and DNA repair(Hara et al., 2000). In mitosis, 
nucleosomes occlude condensin binding(Toselli-Mollereau et al., 2016) and may inhibit 
topoisomerase II mediated decatenation of DNA(Capranico et al., 1990). Due to these 
repressive effects of nucleosomes, eukaryotes utilize nucleosome remodeling 
complexes to facilitate access to the underlying DNA(Clapier and Cairns, 2009). 
Nucleosome remodelers expose nucleosomal DNA by hydrolyzing ATP to slide, 
evict, or restructure nucleosomes (Figure 1-2). The mechanism of sliding is best 
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characterized in the ISWI remodeler. Single molecule studies show that ISWI first forces 
7 bp out of the nucleosome(Deindl et al., 2013), which results in an intermediate 
nucleosome that is sterically strained. To accommodate this strain, nucleosome 
remodelers have been shown to distort the histone octamer(Sinha et al., 2017), 
indicating that they are not strictly moving the DNA around a stationary octamer. DNA is 
then entered the nucleosome, resulting in an unstrained nucleosome that has 
translocated. Interestingly, another well studied remodeler, CHD1, does not distort the 
histone octamer while remodeling(Farnung et al., 2017), suggesting that different 
remodelers may utilize fundamentally different principles to remodel nucleosomes. 
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Figure 1-2. Nucleosome remodeling activities. Nucleosome remodelers provide 
access to nucleosomal DNA by sliding (top), evicting (middle), or restructuring (bottom) 
histone octamers. 
Eviction
H2A.Z
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In contrast to nucleosome sliding, the mechanism of nucleosome eviction by 
remodeling proteins is less characterized. Nucleosome remodelers can slide 
neighboring nucleosomes into each other(Ulyanova and Schnitzler, 2005), which is 
hypothesized to create a stable intermediate whereby DNA continuously wraps around 
a canonical histone octamer and a hexamer lacking an H2A/H2B dimer(Kato et al., 
2017). Further remodeling can displace the hexamer, resulting in an evicted 
nucleosome(Dechassa et al., 2010). The regulation and detailed mechanism of this 
process in unknown. 
Finally, nucleosome remodelers can restructure the histone octamer. By 
loosening histone-DNA contacts within the nucleosome, remodelers can facilitate 
exchange of H2A/H2B dimers(Bruno et al., 2003). This mechanism is commonly 
employed by Ino80 and Swr1 to incorporate and remove H2A.Z throughout the 
genome(Brahma et al., 2017; Mizuguchi et al., 2004). Incorporation of H2A.Z 
nucleosomes destabilizes interactions between H2A/H2B dimers and H3-H4 tetramers 
within the nucleosomes and facilitates transcriptional activation(Suto et al., 2000). 
Nucleosome remodeling proteins 
The SNF2 family of helicases (Figure A-1) are a subfamily of ATP-dependent 
helicases within the SF2 family.  Many members of this family are ATPases with 
nucleosome remodeling activity. The family can be further divided into 5 clades, SNF2-
like, Swr1-like, SSO1653-like, Rad54-like, and Rad5/16-like, named after archetypal 
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members within each clade.  Here, I focus on SNF2-like remodelers including ALC1, 
ISWI, CHD1, HELLS, Mi-2, and SNF2. 
Although remodeling factors can evict and restructure nucleosomes, the primary 
biochemical activity within the Snf2-like family of nucleosome remodelers is the ability to 
slide nucleosomes. All known remodelers within the Snf2-like have a single core 
ATPase subunit that can slide nucleosomes in vitro, which is summarized in Figure 1-3. 
The exception to this is HELLS, which possess DNA-dependent ATPase activity but 
lacks any detectable nucleosome sliding activity(Burrage et al., 2012). 
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Intrinsic 
Remodeling 
Activity References 
ALC1 Yes (Ahel et al., 2009) 
ISWI Yes (Corona et al., 1999) 
CHD7 Yes (Bouazoune and Kingston, 2012) 
CHD1 Yes (Lusser et al., 2005) 
Mi-2 Yes (Wang and Zhang, 2001) 
HELLS No (Burrage et al., 2012) 
Snf2 Yes (Phelan et al., 1999) 
Figure 1-3. Phylogeny of Snf2-like nucleosome remodeling proteins. Tree of Snf2-
like remodelers (adapted from (Flaus et al., 2006)) indicating which proteins possess 
intrinsic nucleosome remodeling activity. 
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Regulation by accessory subunits 
Within the Snf2-like family of nucleosome remodelers, the core nucleosome 
remodeling catalytic subunit is commonly found in complex with non-catalytic subunits. 
For example, hSWI/SNF forms large complexes of 9-12 auxiliary subunits, which are 
stable in 0.5 M NaCl washing(Wang et al., 1996). The effect of non-catalytic subunits on 
the biochemistry and functions of the complex varies depending on the specific 
remodeler and auxiliary subunits, with a few examples detailed below. 
Auxiliary subunits can stimulate the rate of nucleosome sliding. For example, 
ISWI in complex with ACF1 can slide nucleosomes at approximately six times the rate 
of the core ATPase subunit alone(Yang et al., 2006). Similarly, ALC1 has detectable, 
yet minimal nucleosome sliding activity in vitro(Ahel et al., 2009), but this activity is 
greatly enhanced by forming a stable complex with PARP1(Gottschalk et al., 2012). 
Although the ATPase domain of ALC1 is a functional remodeler, it is largely 
autoinhibited by its N-terminal macrodomain. This inhibition is relieved by PARP1(Singh 
et al., 2017). Large multi-protein remodeling complexes can also form, such as 
hSWI/SNF whose core remodeler is BRG and is stimulated by three auxiliary subunits 
BAF155, BAF170 and INI1(Phelan et al., 1999), and associates with many other 
proteins including BAF60a/b/c, BAF57, BAF53a/b and beta-actin. 
In addition to modulating the rate of nucleosome sliding, auxiliary subunits can 
alter the biochemical properties of nucleosome sliding in vitro, which is best exemplified 
by ISWI(Oppikofer et al., 2017). The core remodeling subunit, SNF2H, will partition a 
mononucleosome randomly throughout at 270 bp DNA fragment. Adding the auxiliary 
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subunit RSF causes the remodeling complex to specifically slide the nucleosome to the 
end of the DNA fragment, while the auxiliary subunit BAZ1A shifts the mononucleosome 
to the middle of the DNA fragment. These directionality changes are dictated by the 
auxiliary subunits and not the core ATPase since similar results are observed when the 
ATPase subunit is switched from SNF2H to SNF2L, a closely related ATPase. Although 
dramatic, the physiological significance of these biochemical differences is unclear. 
Lastly, non-catalytic subunits in nucleosome remodeling complexes can be used 
to direct the core ATPase subunit to specific genomic loci. Many remodeling complexes 
harbor domains that can bind specific histone post-translational modifications, which 
can be used to target them throughout the genome. In a seminal study(Wysocka et al., 
2006), it was shown that the PHD finger of BPTF, an auxiliary subunit of ISWI, binds 
H3K4 trimethylation to direct the complex to transcriptional start sites. Accordingly, loss 
of H3K4 trimethylation results in mislocalized ISWI and downstream developmental 
defects. In a recent high-throughput assay(Dann et al., 2017), using a library of 115 
mononucleosomes containing different post-translational modifications, it was shown 
that ISWI in complex with seven distinct subsets of auxiliary proteins was highly 
susceptible to histone modifications throughout the nucleosome and especially within 
the acidic patch, the region on the nucleosome where many chromatin binders engage. 
While Snf2-like remodelers are typically configured as a core remodeling protein 
in complex with numerous auxiliary subunits, an exception to this paradigm is thought to 
be HELLS. HELLS was shown to exist as a monomer in nuclear extracts by size 
exclusion chromatography and sucrose density centrifugation(Myant and Stancheva, 
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2008). It is still possible that HELLS forms larger complexes, however, they are likely 
neither stable nor highly abundant. 
Regulation by H1 
As H1 is intimately associated with nucleosomes, it is likely that H1 has dramatic 
effects on nucleosome remodeling. Indeed, H1 and the remodeler CHD1 bind to similar 
positions on the nucleosome(Farnung et al., 2017), which causes H1 to dramatically 
impede CHD1 mediated remodeling(Lusser et al., 2005). Importantly, remodelers are 
differentially affected by H1, since the remodeler ACF1 seems unaffected by H1(Lusser 
et al., 2005). Similar to non-catalytic accessory subunits, H1 can alter the directionality 
of nucleosome remodelers; in vitro, hSWI/SNF moves nucleosomes to ends of DNA 
fragments, but in the presence of H1, it moves nucleosomes to the center of the same 
fragments(Ramachandran et al., 2003). An interesting case is Arabidopsis DDM1, 
thought to be a HELLS ortholog, which is hypothesized to specifically remodel H1 
containing nucleosomes in vivo based on in vivo DNA methylation patterns(Zemach et 
al., 2013); however, this activity has not been recapitulated in vitro. Currently, only a few 
H1 variants and nucleosome remodelers have individually been studied at present so a 
complete picture on how H1 affects nucleosome remodeling is lacking. However, H1 is 
reported to affect nucleosome spacing in mice(Fan et al., 2003), supporting the 
possibility that H1 influences nucleosome remodelers in vivo. 
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Mitotic regulation and function of nucleosome remodeling complexes 
 The role that nucleosome remodeling complexes play in mitosis, if any, has 
remained a mystery. Intriguingly, many nucleosome remodeling complexes are evicted 
from mitotic chromatin including ISWI(MacCallum et al., 2002), CHD1(Stokes and Perry, 
1995) and Ino80(Hur et al., 2010). Additionally, SWI/SNF is phosphorylated in mitosis, 
which entirely inactivates its remodeling activity(Sif et al., 1998). However, upon mitotic 
exit, nucleosome remodelers are required to re-establish gene expression patterns in 
interphase cells(Krebs et al., 2000). Concurrent with the loss of remodelers known to 
precisely position nucleosomes, mitotic chromatin has been reported to lack any defined 
nucleosome position(Komura and Ono, 2005). Regardless, the physiological role of 
mitotic eviction by nucleosome remodelers is not established. It has been hypothesized 
that nucleosome remodeler eviction is required to facilitate the silencing of many genes 
that is known to occur during mitosis(Palozola et al., 2017). In contrast, it has been 
shown that nucleosome remodeler mediated nucleosome eviction is required to load 
condensin on mitotic chromatin(Toselli-Mollereau et al., 2016), indicating that 
nucleosome remodeling may not be completely absent on mitotic chromatin. Finally, it 
was shown that ISWI binds microtubules during mitosis and is required for chromosome 
segregation and microtubule dynamics during anaphase(Yokoyama et al., 2009), 
suggesting that nucleosome remodelers may also have mitotic functions other than 
sliding nucleosomes. 
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ICF syndrome  
ICF patients 
Since mitotic chromosome architecture is important for transmitting genetic 
material, there are a variety of diseases which cause defects in mitotic chromosome 
formation. One of these, Immunodeficiency, centromeric instability and facial 
dimorphism (ICF Syndrome) is an extremely rare disease with less than 70 reported 
cases as of 2013(Ehrlich et al., 2006; Weemaes et al., 2013). Mitotic chromosome 
formation is defective in ICF patients’ lymphocytes following mitogen stimulation. 
Specifically, chromosomes 1, 9, and 16 harbor long blocks of satellite II and III repetitive 
elements adjacent to the centromere that are typically methylated and 
heterochromatinized.  This juxtacentromeric heterochromatin is typically stretched and 
hypothemylated in ICF patients (summarized in Figure 1-4). Additionally, patients show 
variable immunodeficiencies and facial anomalies. Ultimately, patients with ICF 
syndrome usually die of severe recurrent infections prior to adulthood.  
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Figure 1-4. Chromosome defects in ICF syndrome. Healthy chromosomes 1, 9 and 
16 contain methylated centromeric alpha satellite DNA and methylated juxtacentromeric 
satellite II and III DNA. ICF1, ICF2, ICF3, and ICF4 patients have stretched and 
hypomethylated juxtacentromeric DNA, while only ICF2-4 patients have hypomethylated 
alpha satellite DNA. 
Centromeric,
Alpha satellite
Juxtacentromeric,
satellite II, III
Healthy ICF1 ICF2-4
Cytosine
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Genetic causes of ICF 
A variety of mutations have been identified as causative for ICF syndrome 
(Figure 1-5). Mutations in DNMT3B, a de novo DNA methyltransferase, were the first 
genetic causes identified for ICF syndrome(Hansen et al., 1999; Xu et al., 1999). Most 
DNMT3B ICF mutations map to the C-terminal methyltransferase domain, indicating 
that these patients do not possess a fully functional DNMT3B. Although some patients 
contain DNMT3B null alleles, DNMBT3B is a required gene so these patients are 
always found to have heterozygous compound mutations with a less severe DNMT3B 
mutation. 
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Figure 1-5. Mutational landscape of ICF syndrome. Missense (MS), nonsense (NS), 
frameshift (FS), and deletion (DL) mutations identified in ICF patients. Note, many 
DNMT3B mutations have been identified, only a subset of which are displayed. Data 
was aggregated from(de Greef et al., 2011; Nitta et al., 2013; Robertson and Wolffe, 
2000; Thijssen et al., 2015; van den Boogaard et al., 2017). 
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More recently, ICF patients have been identified with mutations in ZBTB24, 
HELLS, and CDCA7. ZBTB24 is a transcription factor, harboring a DNA-binding AT-
hook domain, eight C2H2 zinc fingers, and a BTB domain thought to facilitate 
homodimerization. ICF patient mutations have been found throughout these domains(de 
Greef et al., 2011), emphasizing the importance of ZBTB24 in ICF syndrome. While the 
exact nature of the ICF mutation’s effect on ZBTB24 function is unclear, the BTB and 
AT-hook domains are required for ZBTB24 activity, indicating that the ICF mutations in 
these domains may partially interfere with ZBTB24 activity(Wu et al., 2016). 
HELLS (discussed below), is a putative nucleosome remodeler. Most ICF patient 
mutations in HELLS are expected to produce null proteins either by frameshift or by 
missense mutations in the conserved ATPase domain(Thijssen et al., 2015). 
Interestingly, mutations in HELLS have been identified that are predicted to only affect 
the C-terminus, suggesting that this domain may be important in ICF syndrome. 
CDCA7 (discussed below) is an uncharacterized CXXC zinc finger containing 
protein. CDCA7 is thought to be a transcription factor under control of c-MYC(Osthus et 
al., 2005), however the molecular function of CDCA7 is not well defined. All known 
CDCA7 ICF mutations map to the highly conserved zinc finger domain(Thijssen et al., 
2015) but their effect on CDCA7 function is unknown. 
 
Molecular Causes of ICF 
ICF syndrome is thought to be caused by defects in de novo DNA methylation, 
since the majority of patients harbor DNMT3BB mutations. Indeed, patient mutations 
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engineered into DNMT3B show reduced, but not eliminated DNA methyltransferase 
activity(Gowher and Jeltsch, 2002). Complete lack of DNMT3B is lethal(Okano et al., 
1999), indicating that ICF is only a partial defect in DNA methylation. DNMT3B ICF 
patient mutations map to the DNA methyltransferase domain, suggesting that defective 
methylation is causative, rather than other reported functions of DNMT3B, such as DNA 
methylation independent transcriptional repression, which maps to the central 
domain(Bachman et al., 2001). In agreement with DNA methylation defects causing 
ICF, stretched juxtacentromeres in ICF patient lymphocytes phenocopy healthy 
lymphocytes treated with 5-azacytidine, a non-methylatable cytidine analog ICF(Viegas-
Pequignot and Dutrillaux, 1976).  
ICF patients show heterogeneous DNA methylation defects throughout the 
genome including at Alu elements, centromeric alpha-satellites, and certain imprinted 
genes(Miniou et al., 1997a; Miniou et al., 1997b; Schuffenhauer et al., 1995). However, 
the defining feature in ICF patients is hypomethylation at the juxtacentromeric 
heterochromatin of chromosomes 1, 9, and 16, the same region at which is stretched 
cytologically(Mora-Bermudez et al., 2007). Since there is only a 7% decrease in total 
genomic cytosine methylation in ICF patient tissue compared to healthy patient 
tissue(Tuck-Muller et al., 2000), it has been suggested that DNA methylation defects at 
this specific genomic locus is the causative molecular defect (Tuck-Muller et al., 2000). 
How (and if) juxtacentromeric hypomethylation directly leads to ICF syndrome is 
unclear. 
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It is also unclear how genetic defects of ICF other than DNMT3B mutations 
cause the disease, however, it is assumed that they all converge on DNA methylation 
defects(Ehrlich et al., 2006). Accordingly, siRNA mediated knockdown of ZBTB24, 
HELLS or CDCA7 in fibroblasts results in reduced satellite DNA methylation(Thijssen et 
al., 2015). Additionally, HELLS has been shown in mouse to facilitate DNMT3B 
mediated DNA methylation(Myant and Stancheva, 2008; Zhu et al., 2006), which may 
explain the contribution of HELLS to ICF syndrome. Recently, it was shown that 
ZBTB24 is required for robust CDCA7 expression(Wu et al., 2016), but how ZBTB24 
and CDCA7 contributes to the HELLS-DNMT3B pathway is completely unknown (Figure 
1-6).  
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Figure 1-6. The understanding of the proteins involved in ICF syndrome at the 
onset of this thesis. The connection between ZBTB24-CDCA7 and HELLS-DNMT3B 
pathways was unresolved. Also, HELLS was a putative remodeling enzyme, but was 
shown to not possess nucleosome remodeling activity in vitro.  
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HELLS and CDCA7 
HELLS 
 Helicase Lymphoid Specific (HELLS, also LSH, PASG, or SMARCA6) was 
initially cloned from thymus tissue(Jarvis et al., 1996), and is an SNF2-like nucleosome 
remodeler due to sequence similarity to the family. Although HELLS has no chromatin 
binding domains common to nucleosome remodelers, it contains a conserved DExx-
HELICc ATPase domain, suggesting it may still possess nucleosome remodeling 
activity (Figure 1-7). Purified recombinant Arabidopsis DDM1 (HELLS homolog), has 
been shown to remodel nucleosomes in vitro(Zemach et al., 2013), and many of HELLS 
functions in mammals (discussed below) have been shown to depend on a functional 
ATPase domain(Ren et al., 2015; Termanis et al., 2016), which is consistent with the 
notion that HELLS is a nucleosome remodeler. However, purified murine HELLS cannot 
remodel nucleosomes in vitro(Zemach et al., 2013), opening the possibility that 
nucleosome remodeling is not a conserved function of HELLS.   
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Figure 1-7. HELLS possess a conserved ATPase domain but lacks chromatin 
binding domains common to nucleosome remodeling complexes. Nucleosome 
remodeling proteins typically contain additional chromatin binding domains including 
Helicase-SANT (HAS), bromo, tandem chromo, and HAND-SANT-SLIDE (HSS) 
domains. Adapted from (Clapier and Cairns, 2009).  
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 The role of HELLS in facilitating DNA methylation is well studied. A primary 
function of DNA methylation is the silencing of repeat elements, and upon knockout of 
HELLS in mouse embryonic fibroblasts (Lsh-/-), repeat elements including long terminal 
repeats and satellites are hypomethylated concurrent with their expression(Yu et al., 
2014). HELLS interacts with DNMT3B(Zhu et al., 2006) and facilitates DNMT3B 
targeting throughout the genome(Xi et al., 2009). Although no remodeling activity has 
been shown for HELLS(Burrage et al., 2012) (discussed above), the ability of HELLS to 
establish DNA methylation at repeat elements requires the ATPase activity of HELLS in 
fibroblasts(Termanis et al., 2016) and stem cells(Ren et al., 2015), leading the field to 
assume that HELLS facilitates DNA methylation by remodeling chromatin. Nucleosomes 
are refractory to DNA methylation by DNA methyltransferase(Felle et al., 2011) so it is 
hypothesized that nucleosome remodeling by HELLS could facilitate DNMT3B access 
to the underlying DNA. In Arabidopsis, where HELLS has been extensively studied, 
heterochromatic H1-containing nucleosomes are a barrier to DNA methylation, which is 
overcome by HELLS remodeling(Zemach et al., 2013). 
 
CDCA7 
 CDCA7 is a relatively uncharacterized protein containing a conserved C-terminal 
CXXC zinc finger domain (Figure 1-8). The CXXC zinc finger motif is a common domain 
found in proteins including DNMT1, Tet1 and MLL1 and has DNA binding activity on 
non-methylated DNA(Frauer et al., 2011).  However, the 4X CXXC zinc finger domain of 
CDCA7 is an atypical member of the family, having little sequence similarity.  
		34 
Specifically, DNMT1 and other canonical CXXC zinc finger proteins harbor two 
CXXCXXC motifs, while CDCA7 harbors 4 split CXXC motifs. CDCA7 was originally 
classified as a direct downstream target of c-Myc(Prescott et al., 2001). Upon 
expression, CDCA7 is thought to interact with Myc to induce cell transformation(Gill et 
al., 2013). In zebrafish where CDCA7 is best characterized, CDCA7 is required for 
hematopoietic stem cell formation(Guiu et al., 2014), however, the precise physiological 
and biochemical role of CDCA7 in each of these processes is not defined.  
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Figure 1-8. The zinc finger domain of CDCA7 is conserved between species and 
paralogs. The zinc finger domains from the indicated CDCA7 species (top) and 
paralogs (bottom) were aligned with ClustalW. The CXXC zinc finger motif is indicated 
with black bars. 
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Vertebrates possess two paralogs of CDCA7 (CDCA7 and CDCA7L), which 
share about 50% sequence identity. The zinc finger domain of CDCA7 is highly 
conserved between species and between paralogs (Figure 1-8), however, the N-
terminus is more divergent (Figure A-2). Although the c-MYC interaction is conserved 
between CDCA7 paralogs(Gill et al., 2013; Hartwell et al., 1970; Huang et al., 2005), the 
functional overlap between the two proteins is unknown. As CDCA7L is upregulated in 
response to CDCA7 knockout in mammalian cells (Motoko Unoki, personal 
communication), there may be compensation between paralogs, complicating the study 
of CDCA7. In addition to CDCA7L, frogs possess a third CDCA7 found in the 
embryo(Peshkin et al., 2015), which I name CDCA7e. 
 
Open questions and significance 
Cell cycle regulation of chromatin composition 
 Although the major components (by mass) of mitotic chromosomes were 
determined decades ago(Hirano and Mitchison, 1994), proteins scarcely detected on 
chromosomes can have dramatic mitotic functions (e.g. (Funabiki and Murray, 2000)). 
Because of this, studies have attempted to catalog the entire set of proteins found on 
interphase(Kustatscher et al., 2014) and mitotic chromatin(Ohta et al., 2010). However, 
no study has systematically identified how the chromatin composition changes 
throughout the cell cycle and how these changes are regulated. Through studying 
individual proteins, it has been shown that many proteins are evicted from mitotic 
chromosomes(Gottesfeld and Forbes, 1997; John and Workman, 1998; Martinez-
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Balbas et al., 1995; Rizkallah and Hurt, 2009), but these findings have been called into 
question(Teves et al., 2016). Recently, it was shown that standard fixation protocols 
used during immunofluorescence cause many proteins to appear to have been evicted 
from mitotic chromatin, even though endogenous tagging and live imaging shows they 
are indeed still bound to mitotic chromatin(Teves et al., 2016). It is therefore important 
to determine the regulation of the mitotic chromatin proteome in the absence of these in 
vivo artefacts. 
 
Molecular basis of ICF syndrome 
 At the onset of this project, there was no known connection between CDCA7-
HELLS and ICF syndrome.  As I began studying these proteins, it was reported that 
mutations in CDCA7 and HELLS cause ICF syndome(Thijssen et al., 2015), but it was 
difficult to reconcile how a variety of proteins (DNMT3B, HELLS, CDCA7, ZBTB24) 
each lead to the ICF phenotype. Phenotypic connections between DNMT3B-
HELLS(Myant and Stancheva, 2008; Zhu et al., 2006) and CDCA7-ZBTB24(Wu et al., 
2016) have been documented, but a unifying hypothesis for the molecular defect 
underlying ICF syndrome is absent. Specifically, since biochemical information about 
each of these proteins is lacking (except for DNMT3B), only speculative hypotheses can 
be proposed for how they are unified.  
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CHAPTER 2: CELL CYCLE REGULATION OF CHROMATIN COMPOSTION 
Results 
An assay to systematically determine the cell cycle and nucleosome regulation of 
chromatin composition 
 For a variety of reasons (discussed in Chapter 1), manipulating chromatin under 
physiological conditions has been challenging. To circumvent these issues, I used 
Xenopus egg extracts, which recapitulate cell cycle events on exogenously added 
chromatin. When added to interphase extract, demembranated sperm DNA will replicate 
and chromatinize with high efficiency(Blow and Laskey, 1986). When the extract is 
cycled into mitosis the chromatin will condense into paired mitotic chromatids, and a 
mitotic spindle will form around the chromatin(Sawin and Mitchison, 1991). Analogously, 
plasmid DNA can be coupled to magnetic beads and will chromatinize when added to 
Xenopus egg extract. When DNA coated beads are added to interphase extract they 
assemble nuclear envelopes and when added to mitotic extract they nucleate 
microtubules, forming bipolar mitotic spindles(Heald et al., 1996). These experiments 
highlight how DNA beads incubated in Xenopus egg extracts resemble physiological 
chromatin more so than in traditional tissue culture extracts. 
 Typically, when adding naked DNA to Xenopus egg extract, histones stored in 
the extract are loaded onto the DNA by HIRA, the canonical replicated-independent 
nucleosome assembly chaperone(Ray-Gallet et al., 2002). To facilitate manipulation 
and study of histones, I preloaded in vitro purified histones onto a tandem array of 19 
nucleosome positioning sequences (Widom’s 601 sequence (Lowary and Widom, 
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1998)) separated by 53 bp of linker DNA. These nucleosome arrays were coupled to 
magnetic beads, and when incubated in Xenopus egg extract, chromatin binding 
proteins associate with the beads. Similar to the physiologically loaded endogenous 
histones, these pre-loaded nucleosome beads can form nuclear envelopes in 
interphase and mitotic spindles in M phase(Zierhut et al., 2014). To identify chromatin 
binding proteins, beads can be recovered from the extract, washed, and the chromatin 
associated proteins are analyzed by Western blotting or mass spectrometry. By 
manipulating the underlying histones or the extract in which the chromatin is incubated, 
I can systematically assess how a variety of factors affect the composition of chromatin 
by Western blotting, immunofluorescence and mass spectrometry. In the paragraphs 
that immediately follow, I describe the method and rational of all experimental 
perturbations I performed to study how the composition of chromatin is regulated 
(summarized in Figure 2-1).  
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Figure 2-1. Schematic of mass spectrometry experiments to determine the 
regulation of chromatin associated proteins. Chromatin beads are incubated in 
Xenopus egg extract, allowing chromatin assocaited proteins to bind. Beads are 
recovered, washed, and chromatin associated proteins are determined by mass 
spectrometry.   
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Histones are fundamental in nearly all chromatin processes; completely depleting 
histones from cellular chromatin results in gene expression dysfunction(Wyrick et al., 
1999) and lethality(Roberts et al., 2002), which makes assessing their contribution to 
the chromosome composition difficult in cellular systems. To overcome these 
limitations, Christian Zierhut established a strategy to deplete and complement histones 
from Xenopus egg extract.  Specifically, Christian Zierhut immunodepleted endogenous 
H3/H4 from Xenopus egg extracts with an H4K12Ac monoclonal antibody and added 
back either naked DNA arrays or nucleosomal DNA arrays coupled to magnetic beads 
to study the role of nucleosomes in physiological processes. Although many histone 
antibodies were tested for H3/H4 immunodepletion, anti-H4K12Ac was most 
effective(Zierhut et al., 2014), consistent with H4 stored in the egg being marked with 
K12Ac(Shechter et al., 2009).  Using this methodology, I could query which chromatin 
binding proteins depend on nucleosomes under physiological conditions. Additionally, 
as most nucleosomes are bound by H1(Van Holde, 1989), I could deplete H1 from the 
extract to determine the specific contributions of the linker histone within the 
nucleosome.  
Histone variants are important contributors to cellular processes with well 
documented roles in transcription(Talbert and Henikoff, 2017). As histones are purified 
from bacteria in my assay, I can incorporate histone variants into the nucleosomal 
arrays with ease. Therefore, I tested the contribution of H3.2 nucleosomes and H3.3 
nucleosomes, which differ in only 4 amino acids. While H3.3, loaded independently of 
DNA replication, is thought to play important roles in transcriptional regulation(Sakai et 
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al., 2009), transcription is generally repressed in Xenopus eggs(Newport and Kirschner, 
1982), allowing us to specifically study the transcription-independent roles of histone 
variants in affecting the chromatin landscape. 
In addition to individual contributions of chromatin factors, I was interested in the 
interaction between multiple factors. Therefore, in the same experiment I assayed the 
combinatorial effect of the cell cycle (interphase vs. mitotic extract), Aurora B (mock vs. 
CPC depletion), and the heterochromatin mark H3K9me3 (H3 vs. H3K9me3 
nucleosomes) on the chromatin composition. These perturbations are expected to have 
connected effects(Fischle et al., 2005). since Aurora B phosphorylates H3S10, which is 
adjacent to H3K9me3 and the cell cycle causes a large array of modifications to the H3 
N-terminal tail and elsewhere on chromatin. Indeed, previous studies have documented 
the combinatorial effects of these histone tail marks, such as the H3K9me3 interactor 
HP1 being evicted by neighboring H3S10ph(Fischle et al., 2005; Hirota et al., 2005), 
providing a precedent for these experiments.  
 
Major and minor determinants of chromosome composition 
 As outlined above, I purified chromatin beads from Xenopus egg extract and 
using mass spectrometry, quantified how chromatin binding proteins were regulated by 
the underlying chromatin and extract conditions. Although I tested the contribution of 
many factors to the proteomic composition of chromatin, the presence or absence of 
nucleosomes had the broadest effect (Figure 2-1A-B, Figure A-3, Figure A-4). I defined 
the cutoff as being enriched greater than 4-fold by the presence or absence of 
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nucleosomes, and observed that only 57.3% of proteins are unaffected by chromatin 
with or without nucleosomes. These proteins, including DNA damage proteins RPA and 
Ku70-80, are likely proteins that bind DNA, but can still interact with DNA in the 
nucleosomal context. 30.5% of proteins exclusively associate with non-nucleosomal 
DNA. Proteins in this class, such as tRNA synthases, are nucleic acid binding proteins, 
which likely are inhibited by nucleosomes. Finally, 12.2% of identified proteins 
exclusively associate with nucleosomes, including core histones and the linker histone 
H1. These proteins are either specifically recruited to nucleosomes (such as RCC1 
(Makde et al., 2010)), or bind DNA in a nucleosome dependent manner. Similarly, the 
cell cycle had a strong effect on how proteins interact with chromatin; 34.9% of proteins 
are affected by the cell cycle (Figure 2-1C). Notably, I detected known mitotic proteins 
(condensin) only on mitotic chromatin and known interphase proteins (MCM complex 
and nuclear pore complex proteins) only on interphase chromatin (Figure A-5), 
supporting effective cell cycle manipulation of the extract. 
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Figure 2-2. Nucleosomes and the cell cycle are the major determinants of 
chromosome composition. Histograms of the number of chromatin associated 
proteins affected by each experimental perturbation. For all proteins identified on 
chromatin, their enrichment on Nucleosomal vs Naked DNA mitotic (A) and interphase 
(B) chromatin, M phase vs interphase nucleosomal chromatin (C), H3.3 vs H3.2 mitotic 
chromatin (D), H3 vs H3K9me3 mitotic chromatin (E), mock depleted vs CPC depleted 
mitotic chromatin (F), and mock depleted vs H1 depleted chromatin (G) are plotted. 
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The overarching effect of nucleosomes and the cell cycle is in sharp contrast with 
the effect of the histone variant H3.3, which had little effect on the composition of 
chromatin. Only 5.4% of proteins were affected by more than four-fold in the presence 
of H3.3 (Figure 2-2D). Of the few proteins that were affected, none could be 
reproducibly verified (Christian Zierhut, personal communication). These data are 
consistent with H3.3 only modifying four amino acids on a 262 kiladalton nucleosome 
particle, which is not expected to largely affect the composition of chromatin. 
Similarly, 85.2% of proteins were unaffected by the heterochromatin mark 
H3K9me3 (Figure 2-2E), indicating that this has little effect on the chromatin 
composition. Although only 12.8% of proteins are specifically recruited to H3K9me3 
chromatin (Figure A-6), these proteins include factors known to be critically important for 
heterochromatin structure such as HP1(Nakayama et al., 2001), which organizes 
heterochromatin into a phase-separated liquid droplet(Larson et al., 2017). This dataset 
provides a rich set of novel candidate proteins which may bind H3K9me3 and play 
important roles in heterochromatin structure and function (Figure A-6). For example, 
ZNF850 (an uncharacterized protein) and ASAP3 (an ADP-ribosylation factor implicated 
in cancer cell invasion(Ha et al., 2008)) have no reported link to heterochromatin.  My 
data suggest that these proteins may either bind H3K9me3 directly or interact with other 
H3K9me3 interactors and warrant follow up studies.  The predictive power of this data 
set is well illustrated with CHD3, which was one of the most abundant proteins binding 
H3K9me3 chromatin. CHD3 is known to be involved in heterochromatin 
organization(Klement et al., 2014), and my data suggest it may be through direct 
		47 
interaction with H3K9me3.  Indeed, following my study, a recent biochemical studied 
showed that CHD3 has enhanced affinity for H3K9me3(Tencer et al., 2017). 
Depletion of the CPC (Figure A-7) and linker histone H1 (Figure A-8) only affect 
14.4% and 14.8% of the chromatin proteome, respectively, indicative of a relatively 
minor and specialized effect on chromatin (Figure 2-2F,G). Combined with the previous 
results, these data show that nucleosomes and the cell cle are the key determinants of 
global chromatin composition, while other perturbations like histone variants, histone 
modifications, linker histones, and regulatory kinases impart cellular functions only by 
modulating specific proteins. 
 
Nucleosomal and cell cycle regulation of chromatin 
 To uncover insights into the regulation of mitotic chromosome assembly, I 
specifically focused on nucleosome-dependent chromatin binding proteins and how 
chromatin is regulated by the cell cycle, since these are the major determinants of 
chromatin composition (Figure 2-2) and have been relatively unstudied. 
 Unexpectedly, many proteins that possess DNA binding activity in vitro show 
nucleosome dependent chromatin association in physiological egg extracts 
(summarized in Figure 2-3A). For example, the linker histone H1 has well established 
DNA binding activity in vitro(Ura et al., 1996), but requires nucleosomes for chromatin 
recruitment. While conducting these experiments, it was shown that in vitro H1 binds to 
the dyad of the nucleosome and constrict dynamics of the DNA entering and exiting the 
nucleosome(Bednar et al., 2017). My data suggest that H1 may be specifically recruited 
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to this position in cells and avoids non-specific interactions with non-nucleosomal DNA. 
Similarly, many other DNA binding proteins are highly abundant exclusively on 
nucleosomal chromatin including the histone chaperone complex FACT and RCC1, a 
guanine nucleotide exchange factor required for mitotic spindle assembly (Figure 2-3B). 
I was surprised to see topoisomerase II exclusively on nucleosomal DNA as it is known 
to act on naked DNA (Figure 2-3A,C). However, as expected, purified topoisomerase II 
preferentially associated with naked DNA over nucleosomal DNA (Figure 2-3D). 
Collectively, these data show that proteins with in vitro DNA may still require 
nucleosomes to associate with chromatin in vivo. I envision that regulation by 
chaperones or other signaling methods restricts these proteins to nucleosomal DNA 
(see Chapter 4). 
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Figure 2-3. Proteins with DNA binding activity require nucleosomes to associate 
with physiological chromatin. (A) Summary of most abundant nucleosome-
dependent, chromatin associated proteins. Naked DNA or chromatin beads were 
incubated in mitotic Xenopus egg extract, recovered, washed, and the chromatin 
associated proteins were analyzed by mass spectrometry. The most abundant proteins 
that were at least 5-fold enriched on nucleosome beads over naked DNA are 
summarized. (B, C) Western blot analysis of nucleosome dependent, chromatin 
associated proteins. Chromatin beads were treated as in (A). (D) Purified 
topoisomerase II interacts with naked DNA and nucleosomes in vitro. Purified 
topoisomerase II was incubated with DNA or nucleosome beads. Beads were 
recovered, washed, and chromatin bound topoisomerase II was visualized by 
coomassie staining. 
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A catalog of how a variety of chromatin binding proteins are regulated throughout 
the cell cycle is shown in Figure 2-4. Of the proteins enriched on mitotic chromatin 
(Figure 2-4B), many have known functions in mitosis including RCC1, which is required 
for mitotic spindle formation(Carazo-Salas et al., 1999) and H1, which is required for 
mitotic chromosome condensation(Maresca et al., 2005). The mitotic specific-proteins 
also include relatively unstudied proteins such as CIP2A, an inhibitor of PP2A, and 
C1QPB, a novel interactor of the CPC (Michael Wheelock, personal communication). 
These data point to a mitotic role for these proteins, and warrants follow up studies. 
65.1% of proteins are found on chromatin in interphase as well as M phase, and 
likely function throughout the cell cycle (Figure 2-4C). Interestingly, many proteins 
involved in repairing DNA damage (ATM, MRE11, BLM, WRN, RPA) are found on 
chromatin throughout the cell cycle (Figure 2-4C). Although the DNA damage response 
is largely attenuated in mitosis(Giunta et al., 2010), these results suggest a primary 
DNA damage response (including ATM and MRE11) still occurs throughout the cell 
cycle in the frog egg. Finally, I see a large fraction of proteins (14.7%) that bind 
specifically to interphase specific chromatin and are evicted from mitotic chromatin 
(Figure 2-4D). Although the mitotic eviction of many proteins has been individually 
documented (e.g. (Rizkallah and Hurt, 2009) and reviewed in (Gottesfeld and Forbes, 
1997)), this is the first global assessment of how the proteome is regulated in mitosis. 
Of the proteins specific to interphase chromatin, I found proteins involved in DNA 
replication (MCM2-7), nuclear envelope structure (Lamin A), DNA repair (MSH2-6), and 
nucleosome assembly and remodeling. The functional consequences of the global 
		52 
eviction of chromatin binding proteins during mitosis is unknown, however, I speculate 
that their removal may facilitate the loading of mitosis-specific proteins required to 
condense and segregate chromosomes accurately (see below). 
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Figure 2-4. Summary of the cell cycle regulation of chromatin associated 
proteins. (A) Abundance of all proteins on M phase and interphase chromatin. 
Nucleosome beads were incubated in M phase or interphase extract, recovered, 
washed and the chromatin associated proteins were analyzed by mass spectrometry. 
The abundance of each identified protein is plotted. Proteins identified only on a single 
sample are plotted along the axes. (B-D) Individual proteins from (A). For each mitosis 
specific (B), cell cycle independent (C), or interphase specific (D) protein, the 
abundance on chromatin, the enrichment on M phase over interphase chromatin, and 
the nucleosome dependency are reported.  
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Nucleosomal and cell cycle regulation of mitotic chromosome structural proteins 
 As discussed in Chapter 1, topoisomerase II and condensin are the two primary 
molecules involved in shaping mitotic chromosomes. In my mass spectrometry 
experiments, I uncovered an interesting divergent regulation of these two factors. 
 Consistent with condensin’s primary function occurring during mitosis, I saw all 
subunits of condensin I specifically recruited to mitotic chromatin (Figure 2-5A). 
Although purified condensin harbors DNA binding activity, I saw an exclusion of 
condensin from interphase chromatin (Figure 2-5A), suggesting that additional cell cycle 
regulations are imparted on its DNA binding activity. Combined with published data that 
shows condensin’s ATPase activity is activated in mitosis(Kimura et al., 1998), these 
data show that condensin acts specifically during mitosis via enhanced chromatin 
targeting and activity. Surprisingly, I saw that condensin preferred naked DNA beads 
over nucleosome beads (Figure 2-5B,C). At the time of these experiments, this result 
was in direct contradiction to a published study showing that condensin is recruited to 
nucleosomes in mitosis(Tada et al., 2011). Since condensin is thought to condense 
mitotic chromosomes through its positive DNA supercoiling activity, this result suggests 
that nucleosomes may be refractory to condensin mediated chromosome shaping. 
Following these experiments, condensin’s exclusion from nucleosomal DNA was 
independently verified by multiple labs(Kinoshita et al., 2015; Shintomi et al., 2017; 
Toselli-Mollereau et al., 2016). Although reduced, condensin could be detected on 
nucleosomal chromatin, which I interpret as condensin still having affinity for 
nucleosomal DNA or that it can bind the linker region between nucleosomes, however, 
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the canonical condensin-DNA structure requires ~190 base pairs of free DNA(Bazett-
Jones et al., 2002). As mitotic chromosomes are largely composed of nucleosomes, the 
ability of condensin to act in the context of nucleosomes is likely required for its function. 
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Figure 2-5. Differential regulation of condensin and topoisomerase II. Abundance 
of condensin (A, B, C) and topoisomerase II (C, D, E) on the indicated chromatin 
measured by mass spectrometry (A, B, D, E) or Western blotting (C). 
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In contrast to condensin, topoisomerase II is recruited to chromatin 
independently of cell cycle phase (Figure 2-5C,D). Unexpectedly, although 
topoisomerase II is well documented to enzymatically act on naked DNA(Berger et al., 
1996), I find that the association of topoisomerase II with chromatin requires 
nucleosomes in mitosis, and has a strong preference for nucleosomes in interphase 
(Figure 2-5 C,E). This indicates that although topoisomerase II acts on naked DNA, its 
interaction with the DNA substrate is transient and requires nucleosomes for stable 
association. While carrying out this study, an independent group verified that 
topoisomerase II interacts with histones to associate with chromatin and further 
identified the H3 tail as important in the recruitment(Lane et al., 2013).  
 If topoisomerase II is associated with chromatin throughout the cell cycle, how 
does it exclusively shape mitotic chromosomes during M phase? To address this 
question, I assayed topoisomerase II’s enzymatic activity by monitoring decatenation of 
kinetoplast DNA. Kinetoplast DNA, mitochondrial DNA isolated from Crithidia, 
fasciculate, is highly catenated circular DNA but when added to Xenopus egg extract 
topoisomerase II decatenates the DNA resulting in individual circles, which can be 
resolved by gel electrophoresis (Figure 2-6A). I find that topoisomerase II decatenation 
activity is exclusively activated during mitosis (Figure 2-6B). However, my previous 
experiments were done on naked DNA. Although nucleosomes have been suggested 
inhibit topoisomerase II activity(Capranico et al., 1990), the mitotic chromosome is 
coated with nucleosomes, which raises the possibility that topoisomerase II is largely 
inactive on mitotic chromatin. However, by making nucleosomal kinetoplast DNA by salt 
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dialysis (Figure 2-6C) I saw that topoisomerase II has only slightly reduced activity on 
nucleosomes, indicating that topoisomerase II is still enzymatically functional within the 
context of nucleosomal chromatin. Collectively, these results show that although 
topoisomerase II associates with nucleosomal DNA throughout the cell cycle, 
topoisomerase II enzymatic activity is activated in mitosis where it is can facilitate 
decatenation of sister chromatids even in the presence of nucleosomes. Furthermore, I 
propose that topoisomerase II has enhanced binding affinity to nucleosomes that 
overcomes its slightly reduced activity on the nucleosomal substrate. 
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Figure 2-6. Topoisomerase II decatenation activity is stimulated in mitosis and 
can decatenate a nucleosomal substrate. (A) Kinetoplast DNA (kDNA) decatenation 
to assay topoisomerase II activity. kDNA was added to mock depleted or topoisomerase 
II depleted mitotic Xenopus extract. At the indicated time point, the DNA was extracted 
and resolved by agarose gel electrophoresis. kDNA is highly catenated and remains in 
the well while topoisomerase II dependent decatenation results in circular DNA that 
enters the gel. (B) Topoisomerase II is stimulated in mitosis. kDNA was added to mitotic 
or interphase Xenopus extract. At the indicated time point, the DNA was extracted and 
resolved by agarose gel electrophoresis. (C) Topoisomerase II can act on a 
nucleosomal substrate. kDNA or nucleosomal kDNA, generated by salt dialysis with 
histones, was added to mitotic Xenopus extract. At the indicated time point, the DNA 
was extracted and resolved by agarose gel electrophoresis (right). To verify the kDNA 
chromatinization, the nucleosomal kDNA was digested with MNase (right). 
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 Except for nucleosomes and the cell cycle, the chromatin recruitment of 
condensin and topoisomerase II is largely unaffected by experimental perturbations 
(Figure 2-7). Their association with chromatin in not affected by the heterochromatin 
mark H3K9me3 (Figure 2-7A), the mitotic kinase Aurora B (Figure 2-7B), the linker 
histone H1 (Figure 2-7C) or the histone variant H3.3 (Figure 2-7D). As condensin and 
topoisomerase II play pivotal roles in mitosis, this data is consistent with the function of 
these proteins needing to act globally and be immune to the specific chromatin context.  
		64 
 
 
 
 
 
Figure 2-7. Condensin and topoisomerase II are largely unaffected by the 
underlying chromatin. The abundance of SMC2-SMC4 (condensin) and 
topoisomerase II on H3 and H3K9me3 (A), mock depleted and CPC depleted (B), mock 
depleted and H1 depleted (C), and H3.2 and H3.3 nucleosome beads incubated in 
mitotic Xenopus egg extract, determined by mass spectrometry.  
H3K9me3
H3
H3
K9
me
3
0
1.0 1009
2.0 1009
3.0 1009 SMC2
SMC4
Topo II
Ab
un
da
nc
e 
on
 
C
hr
om
at
in
 B
ea
ds
 (a
.u
.)
H1
0
2.0 1009
4.0 1009
6.0 1009
8.0 1009
1.0 1010 Topo II
SMC2
SMC4
Ab
un
da
nc
e 
on
 
C
hr
om
at
in
 B
ea
ds
 (a
.u
.)
CPC
ΔM
oc
k
ΔC
PC
0
1.0 10 09
2.0 10 09
3.0 10 09
4.0 10 09 SMC2
Topo II
SMC4
Ab
un
da
nc
e 
on
 
C
hr
om
at
in
 B
ea
ds
 (a
.u
.)
H3.3
H3
.2
H3
.3
0
1.0 1009
2.0 1009
3.0 1009
4.0 1009 SMC2
SMC4
Topo II
Ab
un
da
nc
e 
on
 
C
hr
om
at
in
 B
ea
ds
 (a
.u
.)
ΔM
oc
k
ΔH
1
A B
C D
		65 
Cell cycle regulation of nucleosome remodeling and assembly complexes 
 Among the proteins that are evicted from mitotic chromatin are nucleosome 
remodelers. Nearly all proteins found in nucleosome remodeling complexes are evicted 
from mitotic chromatin including components of ISWI, NURD, INO80, among others 
(Figure 2-8A). The main exception to this is the FACT complex, which is only slightly 
enriched on interphase chromatin relative to mitotic chromatin (Figure 2-8A,B). In 
addition to being evicted from mitotic chromatin, most nucleosome remodelers are 
dependent on nucleosomes for chromatin association, consistent with the nucleosome 
being the substrate of their enzymatic reaction. As both FACT and ISWI depend on 
nucleosomes (Figure 2-8C, E), but are differentially regulated by the cell cycle, it is likely 
that not all nucleosomal remodelers are under control of the same regulatory module. 
Indeed, the mechanism of mitotic eviction appears to be different between remodeling 
complexes; ISWI is evicted from mitotic chromatin in an Aurora B dependent manner 
(Figure 2-8D) while other remodeling/assembly complexes such as NURD and HIRA 
are evicted from mitotic chromatin independently of Aurora B (Figure 2-8F).  
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Figure 2-8. Nucleosome remodeling and assembly proteins are evicted from 
mitotic chromatin. (A) The enrichment of each nucleosome remodeling and assembly 
protein on interphase relative to mitotic nucleosome beads was determined by mass 
spectrometry. Whether the proteins are dependent on nucleosomes for chromatin 
association is also indicated. Quantification of the amount of FACT (B, C), ISWI (D, E), 
and HIRA (F, G) bound to the indicated chromatin beads measured by mass 
spectrometry (B, D, E) or Western blotting (C, E, G).  
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 Similar to nucleosome remodelers, the main proteins involved in nucleosome 
assembly are evicted from mitotic chromatin (Figure 2-8A). This includes the histone 
chaperones required nucleosome assembly Asf1, HIRA, and CAF1. As opposed to 
nucleosome remodelers, which largely require nucleosomes, HIRA is specifically 
recruited to naked DNA in interphase (Figure 2-8G). This suggests a temporally 
segregated model whereby histone chaperones are recruited to sites of naked DNA to 
deposit histones in interphase, followed by recruitment of nucleosome remodelers, 
which properly position the nucleosomes. 
 
Cell cycle regulation of nucleosome assembly 
Due to the striking mitotic eviction of proteins involved in nucleosome assembly 
and remodeling, I hypothesized that mitotic eviction of nucleosome remodelers and 
histone chaperones would result in diminished nucleosome assembly during mitosis. To 
test this, I used a supercoiling assay, whereby relaxed plasmid DNA is added to 
Xenopus egg extract, and nucleosome incorporation is monitored by measuring the 
supercoiling state of the plasmid (every incorporated nucleosome increases the linkage 
number by -1, which migrates faster by gel electrophoresis). As expected, interphase 
extract possesses robust nucleosome assembly activity (Figure 2-9A). Surprisingly, 
concomitant with eviction of HIRA and other nucleosome remodeling complexes, mitotic 
extract showed markedly reduced nucleosome assembly activity (Figure 2-9A). While 
interphase extract completely chromatinized a plasmid in 90 minutes, very few histones 
had been deposited on mitotic plasmids after 180 minutes. 
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Figure 2-9. Nucleosome assembly is suppressed in mitosis independent of the 
CPC. (A) Agarose gel analysis of relaxed plasmid chromatinized in mitotic and 
interphase Xenopus egg extract. At the indicated times, the plasmid was purified from 
the extract, and the supercoiling state was determined. Nucleosome loading results in a 
supercoiled plasmid, which migrates faster than relaxed plasmid. The cell cycle 
manipulation was verified by Western blotting the cell lysate using an antibody that 
recognizes phosphorylated Cdk1 substrates (right). (B) Agarose gel analysis of relaxed 
plasmid chromatinized in mock and CPC depleted mitotic Xenopus egg extract, 
processed as in (A). The CPC depletion was verified by Western blot analysis of 
INCENP (right).  
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 Since some remodelers including ISWI and HELLS are evicted by mitotic 
chromatin by Aurora B, I wondered if reduced nucleosome assembly was downstream 
of Aurora B activity. However, depleting Aurora B had no effect on nucleosome 
assembly kinetics (Figure 2-9B). Although purified ISWI can catalyze nucleosome 
assembly activity in vitro(Ito et al., 1999), this result is consistent with ISWI depletion 
having no effect on nucleosome assembly kinetics in Xenopus egg extract(MacCallum 
et al., 2002). 
 Since Aurora B does not affect nucleosome assembly and is only responsible for 
a fraction of nucleosome remodelers and assembly proteins being evicted from mitotic 
chromatin, I sought to identify how other factors might be regulated. Specifically, I 
focused on HIRA, the histone chaperone required for replication-independent 
nucleosome assembly(Ray-Gallet et al., 2002). As discussed above, HIRA is evicted 
from mitotic chromatin in a manner independent of Aurora B (Figure 2-8F), and 
specifically, the protein is recruited to naked DNA (Figure 2-8G). HIRA deposits the 
histone variant H3.3 onto naked DNA(Ricketts et al., 2015), however, since my 
chromatin was made with H3.2, it is possible that HIRA was excluded from H3.2 
nucleosomes but could still interact with H3.3 nucleosomal chromatin. Nevertheless, 
HIRA did not bind chromatin beads containing H3.2 nor H3.3 chromatin, showing that 
indeed, HIRA only interacts with naked DNA regardless of histone variant (Figure 2-
10A). 
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Figure 2-10. Plx1 mediated eviction of HIRA from DNA beads in mitosis. (A) 
Western blot analysis of naked DNA, H3.2 nucleosome or H3.3 nucleosome beads 
isolated from M phase or interphase extract depleted of H3/H4. (B) Western blot 
analysis of DNA beads isolated from M phase or interphase extract (+/- BI2536). (C) 
Western blot analysis of Naked DNA, H3.2 nucleosome or H3.3 nucleosome beads 
isolated from M phase extract depleted of H3/H4 (+/- BI2536).  
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 Through testing a variety of possible causes of the mitotic eviction of HIRA, I 
identified the mitotic kinase Plx1 as being responsible for the mitotic eviction of HIRA 
(Figure 2-10B, C). HIRA mitotic eviction from chromatin beads (Figure 2-10B, C) and 
sperm chromatin (Figure 2-11A) was completely abolished when adding the Plx1 
inhibitor BI5236(Steegmaier et al., 2007). Interestingly, even following Plx1 inhibition, 
HIRA only interacted with naked DNA and could still not bind H3.2 or H3.3 nucleosomes 
(Figure 2-10C). In contrast, HIRA chromatin localization to sperm (Figure 2-11B) or 
DNA beads (Figure 2-10B) was not affected by BI5236 in interphase extract, consistent 
with Plx1 being auto-inhibited in interphase(Ghenoiu et al., 2013).   
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Figure 2-11. Plx1 mediated eviction of HIRA from sperm chromatin in mitosis. (A-
B) Immunofluorescence of HIRA on replicated interphase (A) or mitotic (B) sperm 
chromatin chromatinized in Xenopus egg extract. Scale bar 15 µm.   
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Plx1 targets can be identified by the presence of a phosphorylated Polo box 
domain binding motif, S[S/T], which recruits Plx1 to its substrate for further 
phosphorylation(Elia et al., 2003a; Elia et al., 2003b). Since chromatin localization of 
HIRA is regulated by Plx1, I wondered if it was a direct target of the kinase. Indeed, 
HIRA harbors a Polo Box domain binding motif (Figure 2-12A), and is gel-shifted in 
mitosis in a Plx1 dependent manner (Figure 2-12B), suggesting that HIRA may be a 
direct target of Plx1. In agreement with this hypothesis, HIRA is a reported interactor of 
Plk1(Kettenbach et al., 2011). 
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Figure 2-12. HIRA harbors a Polo box binding motif and displays a phospho-
dependent gel shift in mitosis. (A) Alignment of HIRA from the indicated species. The 
Polobox binding motif is highlighted in red. If followed by Proline, the Polo box binding 
motif is also a Cdk1 phosphorylation consensus site. (B) Western blot analysis HIRA in 
mitotic or interphase Xenopus extract (+/- BI2536). Where indicated, the extract was 
treated with lambda phosphatase.  
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As HIRA is the major histone chaperone required for replication-independent 
nucleosome assembly, I wondered if Plx1 mediated eviction of HIRA is responsible for 
the previously-identified mitotic suppression of nucleosome assembly (Figure 2-9A). By 
monitoring plasmid nucleosome assembly kinetics, upon Plx1 inhibition by BI2532, I 
saw a dramatic increase in nucleosome assembly kinetics in mitosis to near interphase 
levels (Figure 2-13A). Although BI2532 is reportedly specific for Polo-like kinase 1, it 
also has off-target inhibitory activity on Polo-like kinase 2 and 3(Steegmaier et al., 
2007). The Xenopus egg has no detectable Plk2, but contains Plk3 (23 nM)(Wuhr et al., 
2014), making the previous results inconclusive. Importantly, immunodepleting Plx1 
from Xenopus egg extracts results in a similar increase in mitotic nucleosome assembly 
kinetics (Figure 2-13B), indicating that the results are not due to off-target effects of 
BI5236. As expected, neither BI2532 nor Plx1 depletion had any effect on nucleosome 
assembly in interphase extracts, since Plx1 inhibition has no effect on HIRA in 
interphase. 
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Figure 2-13. Plx1 mediated suppression of nucleosome assembly in mitosis. (A) 
Agarose gel analysis of relaxed plasmid chromatinized in mitotic or interphase Xenopus 
egg extract (+/- BI 2536). At the indicated times, the plasmid was purified from the 
extract, and the supercoiling state was determined by agarose gel electrophoresis. (B) 
As in (A) except mock or Plx1 depleted Xenopus egg extract was used. 
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 Collectively, these data show that the action of multiple mitotic kinases are 
responsible for evicting nearly all nucleosome remodeling proteins, at least in part to 
suppress mitotic nucleosome assembly. Specifically, Plx1 regulates the association of 
HIRA with chromatin and ultimately suppresses nucleosome assembly in mitosis. The 
physiological implications of this regulation are discussed in the following section. 
 
Discussion and perspective 
The global landscape of cell cycle regulated chromatin proteins 
 Previous studies have looked at the chromatin proteome in 
interphase(Kustatscher et al., 2014) and mitosis(Ohta et al., 2010) individually but have 
not looked directly at how the cell cycle controls the chromatin proteome. However, 
countless studies have tracked individual proteins by immunofluorescence and have 
noted cell cycle regulation.  
 Recently, immunofluorescence studies that report the mitotic eviction of 
chromatin proteins have been called into question(Teves et al., 2016). Apparently, a 
large number of proteins that are shown to be evicted from mitotic chromatin by 
immunofluorescence such as Sox2, Oct4, Essrb, Klf4, Sp1, Foxo1, and Foxo3a do not 
show similar behavior when endogenously tagged GFP constructs are monitored. The 
authors reason that formaldehyde gradients that naturally occur as the fixative enters 
the cell, coupled with high off-rates of DNA binding proteins, may “extract” the protein 
off chromatin as the sample is fixed. This mechanism would apply to all antibodies and 
challenges all previous reports of proteins being evicted from mitotic chromatin 
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determined by immunofluorescence. A second group has independently verified this 
phenomenon(Lerner et al., 2016). Interestingly, it is reported that methanol fixation may 
not have this problem(Lerner et al., 2016), at least in one tested case. 
 In the work presented here, since no fixation is involved, I avoid the 
complications associated with fixation-based methods and get a proteome-wide view of 
how the cell cycle regulates chromatin binding proteins. This allowed me to 
unambiguously determine the mitotic eviction of a variety of proteins including HIRA, 
Asf1, ISWI, and HELLS-CDCA7. Although some of these proteins are confirmatory, 
such as HIRA(De Lucia et al., 2001), these confirmations are required considering the 
artefacts involved in formaldehyde based fixation methods. 
 Additionally, I was able to identify known and novel mitotic binding proteins. As 
discussed previously, the mitotic chromatin beads are highly coated with condensin, in 
agreement with condensin being a major chromatin associated protein complex(Hirano 
and Mitchison, 1994). I also identified several proteins that have previously unknown 
functions in mitosis, which warrant further study.  For example, CIP2A was exclusively 
enriched on mitotic chromatin and clustered with condensin Figure 3-3B). CIP2A is a 
phosphatase inhibitor (PP2A) with a known role in centrosome separation(Jeong et al., 
2014), however, my results suggest that it may have another mitotic function on 
chromatin. Similarly, GEN1,  is a nuclease known to be required for resolution of 
anaphase ultrafine bridges(Chan et al., 2018) was found exclusively on mitotic 
chromatin.  This finding suggests that GEN1 specifically acts during mitotic to resolve 
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recombination intermediates and may be inactive in the preceding interphase, as has 
previously been hypothesized(Chan and West, 2014). 
 Through these experiments, I identified an interesting regulation of condensin 
and topoisomerase II, major components of mitotic chromosomes.  Specifically, both 
proteins are activated in mitosis, but by different mechanisms. Topoisomerase II 
associates with chromatin throughout the cell cycle, while it is enzymatically activated in 
mitosis.  Alternatively, condensin cannot interact with chromatin in interphase, and only 
associates with mitotis.  Interestingly, I find that although both components prefer naked 
DNA, they can work in the context of nucleosomes, and are robust against a variety of 
chromatin conditions. 
Since I depleted Aurora B, I could determine which mitotic chromatin associated 
proteins depend on the mitotic kinase for localization. However, results from this 
experiment highlighted an important caveat: I noticed that tubulin and many microtubule 
binding proteins co-purified with mitotic chromatin beads in a manner dependent on 
Aurora B. These include alpha tubulin, beta tubulin, RHAMM and MAP4 among others. 
Unfortunately, in Xenopus egg extract, microtubules are locally polymerized near 
chromatin in an Aurora B dependent manner, raising the possibility that microtubules 
(and microtubule binding proteins) are co-purifying with the beads. Because of this, it is 
unclear which of these proteins are bona fide chromatin binders and which are MT 
binders. To parse microtubule interactors from chromatin interactors, the experiments 
need to be repeated in nocodazole, a drug that effectively depolymerizes microtubules 
in Xenopus egg extract. 
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Mitotic eviction of nucleosome assembly and remodeling proteins 
 One of the most striking findings while studying the cell cycle regulation of 
chromatin binding proteins was the global eviction of proteins involved in nucleosome 
assembly and remodeling during mitosis. This includes remodelers ISWI, CHD1, INO80, 
and HELLS-CDCA7, as well as assembly factors such as Asf1, CAF, and HIRA. 
Although mitotic eviction has been previously reported for some of these proteins such 
as HIRA(De Lucia et al., 2001) and CHD1(Stokes and Perry, 1995), these findings 
warrant revisiting due to the previously discussed fixation artifacts. Additionally, I found 
that mitotic eviction of nucleosome assembly/remodeling proteins, including the histone 
chaperone HIRA was concomitant with a decrease in nucleosome assembly rate in 
mitosis. 
 Because nucleosomes are required for mitotic chromosome 
compaction(Shintomi et al., 2017), the finding that nucleosome assembly is repressed in 
mitosis is counterintuitive. These results suggest that if interphase nucleosome 
assembly is incomplete when the cell enters mitosis, the cell has no mechanism to 
complete nucleosome assembly, which could result in de-compacted chromosomes and 
chromosome segregation errors. This could be especially problematic during the early 
embryonic cell cycles, where interphase only lasts 30 minutes(Morgan, 2007) and may 
not have time to completely chromatinize during interphase. However, in the following 
paragraph I detail a hypothesis to reconcile this counter-intuition. 
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 Other than nucleosomes, the major components involved in shaping mitotic 
chromosomes are condensin and topoisomerase II. Interestingly, the action of both 
components is refractory to nucleosomes. Although I show that topoisomerase II is 
specifically recruited to nucleosomes (Figure 2-5C), enzymatic decatenation activity 
prefers non-nucleosomal DNA (Figure 2-6C). Since the enzymatic activity of 
topoisomerase II is important for shaping mitotic chromosomes(Sakaguchi and Kikuchi, 
2004; Samejima et al., 2012), mitotic chromatin containing excess nucleosomes could 
inhibit topoisomerase II mediated chromosome shaping. Similarly, I showed that 
condensin prefers naked DNA over nucleosomal DNA for mitotic chromatin association 
(Figure 2-5C). While this has been independently verified by other groups(Kinoshita et 
al., 2015; Shintomi et al., 2017; Toselli-Mollereau et al., 2016), one report goes as far as 
to say that nucleosomes must be evicted during mitosis in order to facilitate condensin 
loading, and identify Gcn5 and RSC as the factors required for the mitotic eviction of 
nucleosomes(Toselli-Mollereau et al., 2016). As HIRA is very efficient in binding naked 
DNA (Figure 2-8G) and assembling nucleosomes(Ray-Gallet et al., 2002), HIRA activity 
would need to be suppressed to prevent nucleosome re-assembly on recently evicted 
nucleosomes. This would prevent futile nucleosome eviction-reassembly cycles. For 
these collective reasons, mitotic nucleosome assembly may need to be dampened to 
facilitate chromosome shaping. 
To test this hypothesis, the deleterious effects of increased nucleosome 
assembly in mitosis would need to be determined. One way to achieve this would be to 
determine condensin/topoisomerase II activity on mitotic chromosomes formed in Plx1 
		82 
inhibited extracts, which have increased nucleosome assembly kinetics in mitosis. My 
hypothesis would predict decreased condensin/topoisomerase II loading under this 
condition, as well as improper mitotic chromatin compaction. Unfortunately, Plx1 is 
required to remove most cohesin from mitotic chromosomes via the “prophase 
pathway”, causing Plx1 inhibition to result in major mitotic chromosome structural 
defects independent of its role in nucleosome assembly(Sumara et al., 2002). Further 
complicating this experiment, Plk1 was shown to directly interact with condensin to 
facilitate chromosome condensation(Abe et al., 2011). However, my data suggest that 
Plx1-dependent nucleosome assembly suppression is mediated by HIRA 
phosphorylation. Therefore, finding point mutations in HIRA that inhibit its Plx1 
dependent phosphorylation could increase mitotic nucleosome assembly and allow me 
to specifically determine the contribution of nucleosome assembly in mitotic 
chromosome compaction independent of other Plx1 functions. 
The hypothesis that reduced nucleosome assembly facilitates condensin and 
topoisomerase II activity does not explain the mitotic eviction of nucleosome remodelers 
including ISWI, CHD1, INO80, HELLS, and others. A recent study(Nocetti and 
Whitehouse, 2016) in budding yeast may shed light on the biology behind this 
phenomenon. In interphase, nucleosome remodelers precisely position nucleosomes 
often into dense arrays, but in mitosis nucleosome spacing is much more homogenous 
than in interphase. This could alleviate densely packed nucleosomes, exposing free 
DNA, which is required for condensin binding and topoisomerase II activity. Therefore, 
to achieve maximal condensin/topoisomerase II dependent chromosome shaping, 
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reduced nucleosome assembly may need to be coupled to reduced remodeler mediated 
nucleosome packing. However, I note that mitosis specific remodelers (currently not 
identified) may be required to homogenously space nucleosomes. 
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CHAPTER 3: HELLS-CDCA7, A BIPARTITE NUCLEOSOME REMODELING 
COMPLEX 
Results 
Co-regulation of chromatin complexes 
Subunits of stable protein complexes are expected to biochemically co-
fractionate. When combined with mass spectrometry, this principle has been used to 
identify hundreds of soluble protein complexes, many of which were previously 
unknown(Havugimana et al., 2012; Wan et al., 2015). Analogously, I reasoned that 
subunits of chromatin bound complexes would be co-regulated on chromatin. Therefore, 
I used a combination of three different perturbations (cell cycle, ±CPC, ±H3K9me3), to 
determine if protein complexes were co-regulated over eight different chromatin 
conditions. Indeed, manual inspection of known chromatin bound complexes showed
that subunits are similarly regulated within conditions, even if their absolute amounts 
change dramatically between conditions (Figure 3-1A-I). For example, Ku70 and Ku80 
(Figure 3-1A) have near identical levels on various chromatin conditions, consistent with 
them forming a stoichiometric complex on chromatin. Drastic examples include 
condensin, a five subunit complex, which only appears on M phase chromatin (Figure 3-
1F) and MCM2-7, a six subunit complex, which only appears on interphase chromatin 
(Figure 3-1D). 
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Figure 3-1. Subunits of 1:1 stoichiometric protein complexes are co-regulated on 
chromatin. (A-I) Abundance of individual subunits for each protein complex on eight 
different types of chromatin (cell cycle, ±CPC, ±H3K9me3). M: M phase, I: interphase.
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Although many 1:1 stoichiometric complexes can be identified, I also identified 
non-1:1 co-regulated complexes on chromatin (Figure 3-2A-C) such as ATRX-DAXX, 
which binds H3K9me3 chromatin. However, ATRX is ~10 fold more abundant than 
DAXX on chromatin. Consistent with ATRX directly binding H3K9me3(Noh et al., 2015), 
these data suggest that approximately 90% of ATRX associates with chromatin 
independently of DAXX. Similarly, ATR-ATRIP (Figure 3-2B) and Topoisomerase II-
TOPBP1, two complexes known to interact (Figure 3-2C) showed non-1:1 
stoichiometries on chromatin.  
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Figure 3-2. Subunits of non-1:1 stoichiometric protein complexes are co-
regualted on chromatin. (A-C) Abundance of individual subunits for each protein 
complex on the indicated chromatin.  
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 In an attempt to identify novel chromatin associated complexes, I used an 
unsupervised hierarchical clustering and ordering algorithm that identifies similarity 
between the proteomic profiles of different proteins (Van der Laan and Pollard, 
2003)(Figure 3-3A). The algorithm is hierarchical; it first partitioned the data into broad 
categories mostly dependent on the cell cycle: M phase exclusive, M phase enriched, 
interphase exclusive, interphase enriched, and non-discriminant chromatin binding 
proteins. After broad characterization, the algorithm further partitioned the clusters until 
proteins of stable complexes were clustered together. For example, the five subunits of 
condensin cluster within the M phase exclusive cluster (Figure 3-3B). Even protein 
complexes that are only subtly affected by experimental conditions are clustered, such 
as FACT and ATR-ATRIP, which cluster within the interphase enriched cluster (Figure 
3-3C) or Ku70-80, which clusters within the M phase enriched cluster (Figure 3-3D). 
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Figure 3-3. Hierarchical clustering of mass spectrometry data identifies known 
protein complexes. (A) Unsupervised clustering of chromatin associated proteins. A 
heat map of each protein’s abundance on each indicated chromatin condition is 
displayed, with proteins enriched on a given chromatin sample colored yellow. 
Examples of known stoichiometric chromatin associated complexes cluster together and 
are indicated. Fine-grained protein complex clusters (left) and coarse-grained cell-cycle 
clusters (right) are labelled. (B-D) Close-up of individual clusters from (A). The 
dendrogram and individual proteins are labelled from the M phase specific (B), general 
(C) and M phase enriched (D) branches, with the indicated protein complexes 
highlighted in red. 
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HELLS-CDCA7 are co-regulated on chromatin 
 Based on my observation that subunits of protein complexes have similar 
proteomic profiles and cluster together, I sought to identify novel chromatin associated 
protein complexes. Intriguingly, HELLS, a putative nucleosome remodeler, clustered 
with a relatively uncharacterized protein, CDCA7 (introduced in chapter 1) (Figure 3-
4A). HELLS-CDCA7 clustered within the interphase enriched cluster, specifically within 
a branch of the cluster that is modulated by the CPC (Figure 3-4A). As discussed in 
Chapter 1, the Xenopus egg only contains an embryonic paralog of CDCA7(Wuhr et al., 
2014), which I name CDCA7e. Accordingly, I only detected CDCA7e and not CDCA7 or 
CDCA7L peptides on chromatin beads isolated from egg extract.  
		92 
 
 
 
 
 
 
Figure 3-4. HELLS and CDCA7e are co-regulated on chromatin. (A) Close up of 
dendrogram containing HELLS and CDCA7e (red). (B) Abundance of HELLS and 
CDCA7e identified by LC-MS/MS on the indicated chromatin beads.  
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 HELLS and CDCA7e showed a strikingly similar profile on chromatin, where both 
proteins were evicted from mitotic chromatin in a manner dependent on Aurora B, and 
both proteins showed little preference for H3 or H3K9me3 chromatin (Figure 3-4B). 
Western blotting confirmed the Aurora B-mediated cell cycle regulation of HELLS-
CDCA7e (Figure 3-5A) on chromatin beads and immunofluorescence showed that 
HELLS was similarly regulated by Aurora B on sperm chromatin (Figure 3-5B). As 
H3S10 and H3S28 are major mitotic phosphorylation targets of the CPC, I wondered if 
these sites were important in the mitotic eviction of HELLS-CDCA7e. Therefore, I 
generated chromatin beads harboring alanine or aspartic acid to block or mimic 
phosphorylation at these residues, respectively. Interestingly, the CPC mediated 
eviction of HELLS-CDCA7e was entirely unaffected by mutations at these residues 
(Figure 3-5C). ISWI, another chromatin protein known to be evicted from mitotic 
chromatin by the CPC(MacCallum et al., 2002) was similarly unaffected by H3S10 and 
H3S28 phosphorylation (Figure 3-5C). Additionally, HELLS and CDCA7e do not bind H3 
tail peptides incubated in Xenopus extracts (Figure 3-5D), consistent with Aurora B 
mediated regulation of HELLS-CDCA7 occurring independently of histone tail 
phosphorylation. Collectively, these data suggest that the Aurora B mediated mitotic 
regulation of HELLS-CDCA7 may occur by direct phosphorylation of HELLS-CDCA7 or 
through other chromatin phosphorylation events. 
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Figure 3-5. HELLS-CDCA7e is evicted from mitotic chromatin by the CPC. 
 (A) Western blot analyses of HELLS and CDCA7e co-purified with nucleosome beads 
recovered from M phase or interphase mock or CPC depleted extracts. (B) 
Immunofluorescence of HELLS and DAPI staining on mitotic sperm chromatin in mock 
or CPC depleted extract. Scale bar 15 µm. (C) Western blot analyses of proteins co-
purified with nucleosome beads recovered from M phase mock or CPC depleted 
extracts. Nucleosomes containing wild-type H3 (SS), H3S10AS28A (SS), or 
H3S10DS28D (DD) were used. (D). Western blot analysis of proteins co-purified with 
peptide pulldown from mitotic extract and interphase extract. Scrambled H3 peptides 
were used to control for non-specific binding. 
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HELLS-CDCA7 require nucleosomes for chromatin association 
 Similar to many nucleosome remodelers, mass spectrometry analysis 
determined that HELLS-CDCA7e depends on nucleosomes to associate with chromatin 
beads in extract (Figure 3-6A). This dependency was verified by Western blotting and 
occurs in both interphase and M phase (Figure 3-6B). The linker histone only associates 
with nucleosomes (Figure 3-6B) and HELLS has been hypothesized to remodel H1 
nucleosomes(Brzeski and Jerzmanowski, 2003{Zemach, 2013 #286), therefore I 
wondered if HELLS-CDCA7e depends on the linker histone for chromatin association. 
By immunodepleting embryonic H1 and performing mass spectrometry on nucleosome 
beads as before, I observed H1 dependent chromatin association of HELLS on mitotic 
chromatin beads (Figure 3-6C), however, by Western blotting this dependency was not 
seen on interphase chromatin (Figure 3-6D). Parsing this regulation will require further 
studies. 
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Figure 3-6. Histone regulation of HELLS and CDCA7e. (A) HELLS-CDCA7e requires 
nucleosomes to associate with chromatin in M phase. Abundance of HELLS and 
CDCA7e co-purified with nucleosome or DNA beads recovered from H3-H4 depleted M 
phase extracts determined by LC-MS/MS. (B) HELLS and CDCA7e require 
nucleosomes to associate with chromatin in interphase and M phase. Western blot 
analyses of proteins co-purified with nucleosome or DNA beads recovered from M 
phase or interphase H3-H4 depleted extracts. (C) HELLS requires H1 to associate with 
mitotic chromatin. MS analysis of proteins co-purified with nucleosome beads recovered 
from mock or H1 depleted M phase extracts. (D) Abundance of HELLS co-purified with 
nucleosome or DNA beads recovered from H3-H4 depleted M phase or interphase 
extracts determined by Western blotting.  
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Many nucleosome dependent chromatin binding proteins in physiological 
cytoplasmic extract(Zierhut et al., 2014) possess DNA binding activity in isolation, 
including H1(Nightingale et al., 1996), RCC1(Ohtsubo et al., 1989), topoisomerase 
II(Zierhut et al., 2014), and FACT(Winkler et al., 2011). To determine if HELLS and 
CDCA7e also possessed DNA binding activity, I purified maltose binding protein-
CDCA7e (MBP-CDCA7e) from E. coli.  Initial attempts at purifying HELLS from E. coli 
were unsuccessful, so HELLS-calmodulin binding peptide (HELLS-CBP) was purified 
from S. cerevisiae. Indeed, purified HELLS-CBP and MBP-CDCA7e also possess DNA 
binding activity (Figure 3-7) despite their nucleosome-dependency in egg extracts. I 
attempted to determine if their dependency could be recapitulated in vitro on 
mononucleosomes lacking linker DNA, however, HELLS-CBP binding to uncoupled 
beads complicated the results (Figure A-10). These results suggest that under 
physiological conditions, CDCA7e-HELLS is either outcompeted by other endogenous 
DNA binding proteins for binding to naked DNA, or that there is nucleosome dependent 
regulation of HELLS-CDCA7e, for example by RCC1 (discussed below). 
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Figure 3-7. HELLS and CDCA7e have DNA binding activity in vitro. Coomassie 
stained gel of a pulldown of 19x601 DNA beads incubated with MBP, MBP-CDCA7e or 
HELLS-CBP. Uncoupled beads were used to control for non-specific binding. 
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HELLS-CDCA7e form a stoichiometric complex on chromatin 
 As HELLS-CDCA7e showed similar chromatin binding profiles, I hypothesized 
that they form a complex. Endogenous HELLS and CDCA7e interact in reciprocal co-
immunoprecipitation experiments in mitotic Xenopus egg extract (Figure 3-8A-B). 
Exogenously expressed MYC-CDCA7e and HELLS-GFP co-immunoprecipitated in both 
interphase and M phase extract (Figure 3-8C), indicating that the interaction is not cell 
cycle regulated. By comparing the amount of HELLS-CDCA7 in the extract to the 
amount co-immunoprecipitated, I note that very little co-immunoprecipitation occurs, 
indicating that they do not form a stable 1:1 cytoplasmic complex. However, their 
interaction is likely direct since purified HELLS-CBP and MBP-CDCA7e co-
immunoprecipitate in vitro (Figure 3-8D).   
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Figure 3-8. HELLS and CDCA7e interact in extract and in isolation. (A-B) Western 
blot analysis of CDCA7e (A) and HELLS (B) immunoprecipitation from M phase 
Xenopus extracts. Preimmune rabbit IgG was used to control for non-specific binding. 
(C) Western blot analysis of Myc-CDCA7e immunoprecipitations from M phase and 
interphase Xenopus extracts expressing HELLS-GFP and Myc-CDCA7e from mRNA. 
Preimmune rabbit IgG was used to control for non-specific binding. (D) Coomassie 
stained gel of purified HELLS-CBP co-immunoprecipitation with MBP-CDCA7e. Purified 
HELLS-CBP was incubated with MBP-CDCA7e or MBP and immunoisolation was 
performed using beads coupled with anti-MBP antibodies or control IgG.   
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Since HELLS-CDCA7e are co-regulated on chromatin and interact in vitro, I 
tested whether they were co-dependently recruited to chromatin. Depleting HELLS from 
Xenopus egg extract had no effect on CDCA7e recruitment to interphase chromatin 
beads, however CDCA7e depletion resulted in near-abolishment of HELLS chromatin 
association (Figure 3-9A). Mass spectrometry independently verified that CDCA7e 
recruits HELLS to chromatin, and further showed that this dependency persists on 
mitotic chromatin (Figure 3-9B). Importantly, exogenous addition of purified MBP-
CDCA7e could rescue HELLS recruitment in CDCA7e depleted extracts in a dose-
dependent manner (Figure 3-9C). Combined with the observation that CDCA7e can 
bind naked DNA and nucleosome arrays (Figure 3-9D), these results show that 
CDCA7e is the chromatin binding component of the HELLS-CDCA7e complex. 
Importantly, purified CDCA7e can also bind mononucleosomes lacking linker DNA 
(Figure 3-9E), indicating that CDCA7e can be recruited directly to nucleosomal DNA or 
to nucleosomes themselves. 
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Figure 3-9. CDCA7e is the DNA-binding module of the HELLS-CDCA7e chromatin 
associated complex. (A) Western blot analysis of proteins co-purified with nucleosome 
beads recovered from interphase extracts mock depleted or depleted of HELLS or 
CDCA7e. (B) Abundance of HELLS and CDCA7e on interphase and M phase chromatin 
mock depleted or depleted of HELLS or CDCA7e, determined by LC-MS/MS. (C) 
Western blot analysis of proteins co-purified with nucleosome beads purified from 
CDCA7e depleted interphase extract complemented with the indicated concentration of 
MBP-CDCA7e. (D) Coomassie stained gel of a pulldown of nucleosome array or DNA 
beads incubated with MBP-CDCA7e. Uncoupled beads were used to control for non-
specific binding. (E) Coomassie stained gel of a pulldown of mononucleosome beads 
without linker DNA or naked DNA beads incubated with MBP-CDCA7e. Uncoupled 
beads were used to control for non-specific binding. (F) Abundance of HELLS and 
CDCA7e on chromatin beads purified from interphase extracts (top), determined by 
quantitative Western blotting (bottom) (n=6 replicates, SEM is shown). 
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Stable cytoplasmic complexes typically co-deplete all subunits when 
immunoprecipitated from egg extract (e.g. (Okuhara et al., 1999; Sampath et al., 2004)). 
Since neither HELLS nor CDCA7e depletion fail to reproducibly co-deplete the other 
component (Figure 3-9A), I hypothesize that they do not form a stable cytoplasmic 
complex. Instead, they likely only form a stoichiometric complex on chromatin, since 
equimolar amounts of HELLS and CDCA7e were detected across a variety of mass 
spectrometry experiments (Figure 3-4), which was independently verified by quantitative 
Western blotting (Figure 3-9F). 
 
HELLS-CDCA7e is a nucleosome remodeling complex 
 As introduced in Chapter 1, HELLS is a putative nucleosome remodeling 
complex, however, mouse HELLS has no nucleosome remodeling activity in 
isolation(Burrage et al., 2012). I hypothesized that HELLS-CDCA7e forms a functional 
nucleosome remodeling complex. To assay for nucleosome remodeling, I used 
mononucleosome engineered to contain a restriction enzyme site that is protected by 
histones (Figure 3-10A). Upon nucleosome sliding, the restriction site is exposed and 
can be cleaved. Using this assay, I verified that purified HELLS-CBP alone has nearly 
non-detectable nucleosome remodeling activity. However, HELLS-CDCA7e has robust 
nucleosome sliding activity that is dependent on ATP. As expected, purified MBP-
CDCA7e alone has no nucleosome sliding activity (Figure 3-10). 
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Figure 3-10. HELLS and CDCA7e comprise a nucleosome remodeling complex. 
(A) Restriction enzyme accessibility nucleosome remodeling assay with HELLS-CBP 
and MBP-CDCA7e. 601-positioned mononucleosomes with a PstI site engineered 15 bp 
into the nucleosome with 20 bp flanking DNA on each end were incubated with the 
indicated remodeling proteins and PstI. Productive nucleosome sliding exposes the PstI 
site, resulting in cleaved DNA (arrow). Following the reaction, DNA was purified and 
resolved on a 10% polyacrylamide gel and visualized with SYBR gold. (B) Native gel 
nucleosome remodeling assay with HELLS-CBP and MBP-CDCA7e. Center-positioned 
mononucleosomes (same as A) were incubated with the indicated remodeling proteins. 
Reactions were stopped, resolved on a 5% polyacrylamide gel, and visualized with 
SYBR gold. Sliding results in end positioned nucleosomes, which migrate faster. (C) 
Native gel nucleosome remodeling assay. End-positioned (left) or center-positioned 
mononucleosomes (right) were incubated with the indicated remodeling proteins. 
Reactions were stopped, resolved on a 5% polyacrylamide gel, and visualized with 
SYBR gold. (D) Restriction enzyme accessibility nucleosome remodeling assay. 601-
positioned mononucleosomes with a HaeIII site 11 bp into the nucleosome with 60 bp 
flanking DNA on the 3’ end were incubated with the indicated remodeling proteins and 
HaeIII. Productive nucleosome sliding exposes the HaeIII site, resulting in cleaved DNA 
(arrow). DNA was resolved on a 10% polyacrylamide gel and visualized with SYBR 
gold. 
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 Nucleosome remodelers can slide nucleosomes to the end or middle of DNA 
fragments, which can be distinguished by native gel electrophoresis. Using this 
principle, I saw that HELLS-CDCA7e can robustly slide a center-positioned nucleosome 
to the end of a DNA fragment, but has no effect on an end-positioned nucleosome 
(Figure 3-10B). As expected, SNF2h, which slides nucleosomes from the end to the 
center of DNA fragments(He et al., 2006), shows the reciprocal activity (Figure 3-10C). 
Interestingly, in a restriction enzyme-based assay starting with an end-positioned 
nucleosome, I still see sliding activity (Figure 3-11D), indicating that although HELLS-
CDCA7e prefers to end-position nucleosomes, the complex can still mobilize these 
nucleosomes. These results show that indeed HELLS-CDCA7e is a nucleosome 
remodeling complex that requires both components for remodeling activity. 
 Nucleosome remodelers utilize energy from ATP hydrolysis to mobilize 
nucleosomes. As was previously shown(Burrage et al., 2012), HELLS possesses DNA-
dependent ATPase activity (Figure 3-11A,B), even in the absence of CDCA7e. 
Interestingly, CDCA7e increases the ATPase activity of HELLS ~2 fold. Collectively, 
these results show that CDCA7e stimulates HELLS ATPase activity, and couples its 
ATPase activity to productive remodeling. As HELLS-CDCA7e is a bona fide 
nucleosome remodeling complex, these results reconcile previous studies that have 
assumed HELLS is a nucleosome remodeler(Burrage et al., 2012; Ren et al., 2015), 
even though it possesses no nucleosome remodeling activity in isolation. 
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Figure 3-11. (A-B) Quantification of ATPase activity. The indicated proteins were 
incubated with gamma-33P ATP for the indicated times at 37 ˚C (A) or 16 ˚C (B) for the 
indicated time. Reaction was separated by TLC, exposed to a PhosphorStorage screen, 
and the fraction of hydrolyzed ATP was quantified. In (B), mean and standard deviation 
from n = 3 distinct replicates are displayed.   
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HELLS-CDCA7e is required for mitotic chromatin structure 
HELLS has a reported role in facilitating DNA methylation(Myant and Stancheva, 
2008; Zhu et al., 2006), therefore, I tested whether HELLS-CDCA7e depletion had an 
effect on DNA methylation in Xenopus egg extract. Using a radiolabeled nucleotide 
incorporation assay, I saw no defect in replication-coupled DNA methylation following 
HELLS depletion (Figure 3-12A). DNA methylation can also be monitored indirectly in 
Xenopus egg extract. As nuclei replicate, the resulting hemi-methylated chromatin 
acquires H3K23 ubiquitylation, an important transient intermediate in DNMT1 mediated 
DNA methylation(Nishiyama et al., 2013). Disruption of DNA methylation (by depleting 
DNMT1, for example) results in an accumulation of H3K23 ubiquitylation, which can be 
monitored by a slower migrating H3 species. While I saw robust H3 ubiquitylation upon 
DNMT1 depletion, I hardly see an effect following HELLS-CDCA7e depletion, in 
agreement with a functional maintenance DNA methylation pathway in the absence of 
HELLS-CDCA7e (Figure 3-12B). These results contradict the reported role of HELLS in 
DNMT1-mediated DNA methylation in Xenopus(Dunican et al., 2015). However, these 
results are consistent with HELLS-independent DNMT1targeting to chromatin(Yan et 
al., 2003) and no detectable de novo DNA methyltransferases in the Xenopus egg(Wuhr 
et al., 2014). As these are both bulk DNA methylation assays, I note that HELLS-
CDCA7 may still facilitate site-specific methylation in a small portion of the genome that 
I may have missed. 
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Figure 3-12. HELLS and CDCA7e are not required for replication dependent DNA 
methylation maintenance. (A) 3-H SAM incorporation into interphase nuclei replicated 
in mock depleted extract or extract depleted of HELLS or CDCA7e. Geminin was used 
where indicated to inhibit DNA replication. (B) Western blot analysis of Xenopus extract 
and sperm nuclei replicated in Xenopus extract and pelleted. Disruption in DNA 
methylation results in H3 ubiquitylation, indicated by asterisks. 
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 A dramatic phenotype seen in ICF patients is the stretching of juxtacentromeric 
heterochromatin(Smeets et al., 1994). I wondered if this phenotype could be 
recapitulated and studied in Xenopus egg extracts. Replicated, paired chromosomes 
can be visualized in Xenopus egg extracts by diluting mitotic spindles formed in the 
extract, which dissolves the spindle and yields individualized chromosomes(Funabiki 
and Murray, 2000). However, depletion of HELLS-CDCA7e resulted in chromosomes 
with primary constrictions that were indistinguishable from wild type chromosomes. 
 While inspecting mitotic chromosomes, I noticed that at a low frequency, entire 
CDCA7e depleted chromosomes were axially stretched and thin, which were term 
“fragile” (Figure 3-13A,B). In some experiments, all chromosomes were longer, with a 
less noticeable fragile phenotype (Figure 3-13C). This phenotype was also seen upon 
HELLS depletion, but not consistently (compare Figures 3-13 and 3-17, for example). 
Although the exact molecular nature of the mitotic chromosome defect is unknown, 
chromosome length can be rescued by adding exogenous recombinant CDCA7e to 
CDCA7e depleted extract, indicating that the defect is not due to co-depletion of other 
proteins (Figure 3-13D,E). Proper chromosome morphology can be rescued by adding 
back CDCA7e at the start of the experiment, or only after chromosomes have replicated 
during the subsequent M phase, showing that M phase activity of CDCA7e is sufficient 
for its chromosome formation activity (Figure 3-13D,E). However, this experiment does 
not definitively show that HELLS-CDCA7e acts during mitosis under normally 
conditions, since it is possible that HELLS-CDCA7e typically acts only during 
interphase, but if needed, could fulfill its function in M phase. 
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Figure 3-13. CDCA7e is required for proper mitotic chromosome morphology. (A-
B) Chromosomes (examples in A) were formed in mock or CDCA7e depleted extract, 
stained with DAPI and then manually scored for fragility (quantified in B). (C) 
Chromosomes were formed in mock, CDCA7, HELLS or H1 depleted extract, stained 
with DAPI, and the axial length was measured. Each point is the length of an individual 
chromosome. (D-E) Exogenously added MBP-CDCA7e can rescue the chromosome 
morphology defect in interphase or mitosis. Western blot analysis (D) of CDCA7e 
depletion and add-back, and chromosome length measurements (E) from 
chromosomes formed in mock or CDCA7 extract. Where indicated, CDCA7e depleted 
extract was complimented with CDCA7 either during interphase, or after replication in 
the following mitosis. 
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To better understand the mitotic chromosome morphological defect, I stained 
chromosomes with PicoGreen. PicoGreen quantitatively stains DNA, allowing me to 
overcome the confounding effect that Xenopus laevis chromosomes naturally vary in 
length by 3-fold(Session et al., 2016). As expected, there is a linear relationship 
between the total H2B staining and the total PicoGreen staining on chromosomes 
(Figure 3-14A). Using PicoGreen as an estimate for DNA amount, I saw that fragile 
chromosomes are longer than expected for their quantity of DNA (Figure 3-14B,C). 
Additionally, fragile chromosomes have less PicoGreen staining per unit area (Figure 3-
14D). Collectively, these data show that in the absence of CDCA7e, chromosomes tend 
to decompact and become axially elongated, reminiscent of H1 and condensin II 
depletion. Further experiments are required to determine the precise molecular defect. 
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Figure 3-14. CDCA7e depleted fragile chromosomes are decompacted and axially 
elongated. (A) PicoGreen and H2B intensity on individual chromosomes formed in 
Xenopus egg extract. (B) PicoGreen intensity and length measurements for individual 
chromosomes formed in untreated (top) or CDCA7 depleted (bottom) extract. Fragile 
chromosomes are labeled in red. Note that the fragile chromosomes are longer than 
expected for their DNA content. (C) Images of chromosomes from (B). Scale bar 1µm. 
(D) Measurement of average PicoGreen intensity, a surrogate for DNA compaction, on 
fragile and normal chromosomes formed in mock or CDCA7 depleted extract. Each dot 
is a measurement for a single chromosome. 
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ICF patient mutations reveal functions of CDCA7 
Thus far, four CDCA7 mutations have been identified in ICF patients, which each 
map to the conserved zinc finger domain(Thijssen et al., 2015). Interestingly, they are 
all adjacent to a CXXC motif, raising the possibility that the ICF mutations disrupt the 
zinc finger domain (Figure 3-15A). To determine the molecular defect that these CDCA7 
mutations cause, I purified recombinant CDCA7e engineered with three separate 
corresponding patient mutations (R232C, R232H, or R262H). All three tested ICF 
mutants could robustly interact with HELLS, indicating that the HELLS-CDCA7 complex 
can still form in ICF patients (Figure 3-15B,C). In an in vitro DNA binding assay, 
CDCA7e-R232C/H mutations greatly disrupted DNA binding of the protein (Figure 3-
15D). Similarly, these mutations failed to bind sperm chromatin in Xenopus egg extract 
and failed to recruit HELLS to chromatin. Interestingly, CDCA7e-R262H showed robust 
DNA-binding activity in vitro, but could not associate with sperm chromatin in egg 
extract, suggesting that it may have a problem binding nucleosomal DNA (Figure 3-
15E). Collectively, these data indicate that a primary defect of CDCA7 ICF mutations is 
a failure to recruit the HELLS-CDCA7 complex to chromatin under physiological 
conditions. 
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Figure 3-15. CDCA7 ICF patient mutations disrupt DNA binding and fail to recruit 
the HELLS-CDCA7 complex to chromatin. (A) Alignment of CDCA7 zinc finger 
domains from the indicated species. The CXXC motifs are underlined, and residues with 
identified ICF mutations are highlighted in red. (B) Coomassie staining (top) and 
autography (bottom) of HELLS-CDCA7e ICF mutant immunoprecipitation. Recombinant 
MBP-CDCA7e harboring the indicated ICF mutations was immunoprecipitated from 
reticulocyte lysate expressing 35S-labeled HELLS-GFP or GFP. (C) Quantification of 
(B). Mean and range from two independent experiments are plotted. (D) Coomassie 
stained gel of a pulldown of DNA beads incubated with MBP-CDCA7e harboring the 
indicated ICF mutations. Uncoupled beads (bottom) were used to control for non-
specific binding. (E) Western blot analyses of proteins co-purified with chromatin beads 
recovered from interphase extracts mock depleted or depleted of CDCA7e. Beads 
coated with 19x601 naked DNA were chromatinized in interphase extract for 90 min 
prior to addition of 1 µM recombinant MBP-CDCA7e harboring the indicated ICF 
mutations. Following an additional 60 min incubation, chromatin beads were recovered. 
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I next tested whether the CDCA7 ICF patient mutations disrupt chromatin 
remodeling by the complex. Surprisingly, HELLS-CDCA7 harboring ICF patient 
mutations remodeled nucleosomes at a rate similar to wild type HELLS-CDCA7 (Figure 
3-15A). Since the previous remodeling experiments were done with HELLS-CDCA7 in 
excess, it is possible that the ICF mutations have a remodeling defect that is masked by 
having excess protein. I therefore performed the same experiment with equimolar 
remodeler:nucleosome and with nucleosomes in excess. Under these conditions, 
HELLS-CDCA7 harboring ICF patient mutations still remodeled nucleosomes as 
effectively as the wildtype counterpart (Figure 3-15B,C). Collectively, these data 
suggest that in vivo CDCA7e serves two separable functions whereby CDCA7e is 
required to recruit HELLS to chromatin, and once there, CDCA7e activates HELLS 
remodeling activity. The CDCA7 ICF mutations tested here retain the ability to activate 
HELLS remodeling activity, however, they are deficient for chromatin targeting of the 
complex.
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Figure 3-16. CDCA7 ICF patient mutations still stimulate HELLS remodeling 
activity. (A-C) Restriction enzyme accessibility nucleosome remodeling assay. 601-
positioned mononucleosomes (15 nM) with a 34 and 15 bp flanking DNA on the 5’ and 
3’ end, respectively, incubated with the indicated remodeling proteins at their indicated 
concentration and MspI endonuclease. Productive nucleosome sliding exposes an MspI 
site, resulting in cleaved DNA (arrow). After reaction, DNA was purified and resolved on 
a 10% polyacrylamide gel and visualized with SYBR gold. Reactions were performed 
with remodeling proteins in excess (A) or limiting (B-C). 
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Expectedly, CDCA7 ICF mutations that cannot bind chromatin in Xenopus egg 
extract, and cannot recruit HELLS, also could not rescue the chromosome morphology 
defect of CDCA7 depleted chromosomes. Complementation with CDCA7 ICF mutations 
still caused axial elongation of mitotic chromosomes, similar to CDCA7 depletion 
(Figure 3-16A, B). At present, I am unsure if this phenotype is at all connected to the 
stretched juxtacentromeric chromatin phenotype seen in ICF patients (discussed in 
Chapter 5). Collectively, these data show that the DNA binding of CDCA7 and HELLS 
recruitment is required for proper mitotic chromosome structure. 
	123 
Figure 3-17. CDCA7 ICF patient mutations do not rescue the CDCA7 depletion 
chromosome morphology defect. (A) Chromosome length measurements for 
chromosomes formed in mock, CDCA7e, or HELLS depleted extract. Where indicated, 
CDCA7e depleted extract was complimented with MBP-CDCA7 or MBP-CDCA7 
harboring the indicated ICF patient mutations. Each point is the length of a single 
chromosome. (B) Western blot of extract from (A). 
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Discussion and perspective 
A streamlined comparative proteomics method for chromatin-associated protein 
complex identification 
Combining affinity purification of target proteins and MS has long been used to 
identify the composition of protein complexes(Gingras et al., 2007) and has recently 
been performed on over 8,000 bait proteins(Huttlin et al., 2017). This method has the 
advantage of detecting multiple major and minor interactors of the protein of interest 
(approximately 7 interactors per protein on average(Huttlin et al., 2017)). More recently, 
unbiased approaches to identifying soluble protein complexes have been developed by 
combining biochemical fractionation with MS(Wan et al., 2015). Similar to the reasoning 
used in this chapter to identify protein complexes, this method assumes that 
cytoplasmic complexes will biochemically co-fractionate. While providing a rich set of 
potential protein complexes, these methods have required 1,163(Havugimana et al., 
2012) and 6,387(Wan et al., 2015) LC-MS/MS runs, making it infeasible for smaller 
studies. Additionally, it may miss protein complexes that only form in certain contexts, 
such as on chromatin. For example, these methods did not identify HELLS-CDCA7 as a 
complex because HELLS-CDCA7 only forms a stable complex on chromatin and likely 
do not biochemically co-fractionate in the cytoplasm. 
Here I identified known and novel protein complexes from an experiment of only 
8 LC-MS/MS samples, greatly reducing time and cost. Several advances made this 
possible. Most importantly, filtering out proteins that are highly abundant in the 
cytoplasm, but only scarcely detected on chromatin was required. By only using the top 
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70th percentile of enriched proteins, a few bona fide chromatin associated proteins such 
as RUVBL1-2(Magalska et al., 2014) were omitted, but common chromatin 
contaminants such as mitochondria and proteasome proteins were successfully filtered. 
The 70th percentile filter will likely need to be manually adjusted from experiment to 
experiment based on the degree of non-specific co-purifying proteins. I found that a 
combination of highly similar (mock vs. CPC depletion and H3K9me3 vs. unmodified) 
and disparate (Interphase vs. M phase) conditions was important for identifying 
complexes. 
Disparate conditions (such as the cell cycle) allow the identification of complexes 
that are specifically affected by the manipulation, for example, the mitotic eviction of 
HELLS and CDCA7. The principle is to find conditions that affect the largest number of 
proteins possible, thereby partitioning the complexes. Alternatively, highly similar 
conditions serve as an internal control whereby protein complex subunits co-vary across 
different samples due to biological variance. This is exemplified by Ku70-80, which 
largely binds chromatin regardless of the cell cycle stage, Aurora B, or H3K9me3, but 
Ku70 and Ku80 show identical fluctuations between conditions (Figure 3-1). In this 
regard, it would be useful to have biological replicates of the same condition, but refrain 
from averaging the results. By keeping biological replicates separate, one could identify 
co-fluctuations of complexes between replicates. 
 Additionally, focusing on a single subcellular location (chromatin) decreased the 
total number of identified proteins, simplifying the analysis. By simply repeating the 
experiment with more perturbations, for example, by other histone modifications, 
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depleting more chromatin proteins, DNA modifications, and the source of extracts, I 
envision that hierarchical clustering analysis will provide a more comprehensive picture 
of protein complexes that associate with chromatin. 
The role of HELLS-CDCA7 in shaping mitotic chromosomes 
Using the previously described approach to identify novel chromatin bound 
complexes, I identified the HELLS-CDCA7 remodeling complex, and classified its 
biochemical activity. To determine the biological function of HELLS-CDCA7, I generated 
antibodies to facilitate immunodepletion from Xenopus egg extracts. Although I was 
originally looking for ICF-like stretched centromeres in CDCA7 depleted Xenopus 
extracts, I mainly observed whole chromosome axial stretching at a low frequency. We 
are far from understanding how HELLS-CDCA7 contributes to mitotic chromosome 
structure, but here I speculate two different mechanisms by which HELLS-CDCA7 could 
affect chromosome structure: by having a direct effect on the organization of mitotic 
chromatin or indirectly by affecting chromosome structural proteins. 
As cells enter mitosis, large arrays of regularly spaced nucleosomes form(Nocetti 
and Whitehouse, 2016), which may facilitate the polymer melt structure formation of 
condensed mitotic chromosomes(Nozaki et al., 2013). Therefore, HELLS-CDCA7 
mediated chromatin compaction may be a direct result of the nucleosome positioning 
that occurs during mitosis. HELLS-CDCA7 depleted chromosomes may still form rod 
like structures due to the action of condensin and topoisomerase II, which can form 
mitotic rods in the absence of chromatin compaction(Shintomi et al., 2017), but may 
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remain decondensed due to an interphase-like nucleosome positioning. In this regard, it 
will be insightful to determine how HELLS-CDCA7 behaves on nucleosome arrays in 
vitro; although I show that HELLS-CDCA7 slides mononucleosomes to the end of DNA 
fragments, this model predicts that HELLS-CDCA7 might precisely space nucleosome 
arrays in vitro. Additionally, MNase digestion of mitotic chromosomes depleted of 
HELLS-CDCA7 could determine if nucleosome spacing is affected in the fragile 
chromosomes. 
Alternatively to this direct model, HELLS-CDCA7 may indirectly compact mitotic 
chromosomes by facilitating the action of mitotic chromosomal proteins such as 
condensin and topoisomerase II. In chapter 2, I showed that condensin preferentially 
associates with naked DNA and topoisomerase II preferentially acts on naked DNA 
although both can act in the context of nucleosomes. Therefore, by sliding 
nucleosomes, HELLS-CDCA7 may act to expose naked DNA for condensin and 
topoisomerase II action, facilitating that shaping of mitotic chromosomes. This 
mechanism would be reminiscent of the RSC remodeling complex, which has been 
shown to evict nucleosomes to allow condensin to bind mitotic chromosomes(Toselli-
Mollereau et al., 2016). However, since excess condensin I action is thought to result in 
radially thinner and axially elongated mitotic chromosomes, my results are consistent 
with an increase of condensin I. Therefore, HELLS-CDCA7 may slide nucleosomes to 
prevent the erroneous excess association of condensin. Indeed, preliminary results 
showed that CDCA7 depleted stretched chromosomes had abnormally high amounts of 
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condensin I, however, these results were not entirely reproducible and warrant further 
clarification. 
As chromosomes depleted of CDCA7 resemble H1 depletion (Figure 3-13C), 
HELLS-CDCA7 may be in the same functional pathway as H1 to shape mitotic 
chromosomes. Therefore, the connection between HELLS-CDCA7 and H1 requires 
further elucidation. For example, HELLS-CDCA7 may be required to remodel H1-
containing nucleosomes to facilitate condensin loading as described above. Although it 
has been proposed that HELLS preferentially remodels H1 containing 
nucleosomes(Lyons and Zilberman, 2017; Zemach et al., 2013), this has not been 
tested biochemically, and preliminary results indicate that HELLS-CDCA7 remodeling is 
unaffected by H1. However, since I found that HELLS interacts with H1 in soluble 
Xenopus egg extract, follow up studies are required. 
Regardless of whether HELLS-CDCA7 acts directly or indirectly to shape mitotic 
chromosomes, there may be other nucleosome remodelers involved in the process. It 
has been shown that drosophila ISWI mutants have misshaped, thin polytene 
chromosomes(Deuring et al., 2000), somewhat similar to CDCA7 depleted Xenopus 
chromosomes. Therefore, it will be important to look at the role of other remodelers 
alone or in combination with HELLS-CDCA7 in shaping chromosomes. 
At present, it is unclear if the ICF chromosomal stretching defect is related to the 
fragile chromosome defect seen on CDCA7 depleted Xenopus chromosomes. On one 
hand, microscopically the chromosomes appear very similar, even if the defect is 
confined to juxtacentromeric heterochromatin in ICF patients. On the other hand, my 
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results indicate that HELLS-CDCA7 affects chromosome structure in a DNA methylation 
independent manner (Figure 3-11).  This is contradictory to the hypothesis that ICF 
fragile chromosomes are caused in a DNA methylation dependent manner. For this 
reason, I imagine that the two defects are caused by similar, but distinct mechanisms. 
Although the chromosomal main defect associated with CDCA7 depletion in egg extract 
is whole chromosome stretching, I did see local centromeric stretching extremely rarely 
(Figure 3-18). Unfortunately, since these events were so infrequent and also observed 
in mock depleted extracts, I was unable to determine if this event was due to CDCA7 
depletion. Interestingly, these internally stretched regions had an excess of condensin I, 
supporting the hypothesis that excess condensin may cause the stretching phenotype 
associated with ICF syndrome. To study this hypothesis in a more controlled setting, 
condensin immunofluorescence on ICF patient mitotic chromosomes would need to be 
performed. Other than stretching, I was unable to identify other chromosomal defects 
present in ICF patients. There was no indication of rearrangements or multiradial 
chromosomes, however, these events may have been too infrequent to notice. 
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Figure 3-18. Stretched chromosomal regions contain excess condensin. 
Immunofluorescence was performed on chromosomes isolated from Xenopus extracts. 
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Nucleosome dependent DNA binding proteins 
One of the most unexpected findings from Chapter 2 was that many DNA binding 
proteins require nucleosomes to associate with chromatin in physiological extracts. For 
example, the linker histone(Ura et al., 1996) and FACT complex(Li et al., 2005) both 
have reported naked DNA binding activity in vitro, but require nucleosomes in Xenopus 
extract for stable chromatin association. In this chapter, I further studied this 
discrepancy in the context of HELLS-CDCA7. Here I discuss two theories to explain the 
discrepancy. 
Chaperones can inhibit non-specific interactions of proteins with their substrate. 
For example, core histones are typically chaperoned in the cytoplasm, to prevent their 
non-specific and deleterious interaction with DNA(Laskey et al., 1978). I envision a 
similar mechanism may be occurring to prevent DNA binding proteins from non-
specifically interacting with non-nucleosomal DNA. For example, H1 affects local 
chromatin structure by docking on the nucleosome and restricting the dynamics of 
neighboring linker DNA(Bednar et al., 2017). Although it can also interact with naked 
DNA alone, I envision that it’s cytoplasmic chaperone, Nap1(Shintomi et al., 2005), may 
prevent these non-specific interactions and direct H1 specifically to nucleosomes. 
Indeed, in the absence of Nap1, erroneous H1-chromatin aggregates form(Shintomi et 
al., 2005). I speculate other nucleosome-dependent DNA binders may act in a similar 
manner. 
Alternatively to chaperones, RCC1 mediated Ran-GTP signaling may be required 
for DNA binding proteins to associate with chromatin. Many proteins are sequestered in 
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the cytoplasm by importins. Chromatin bound RCC1 generates Ran-GTP, which 
releases the cargo from sequestration. Importantly, RCC1 requires nucleosomes for 
chromatin association(Makde et al., 2010; Zierhut et al., 2014) and full catalytic 
activity(Nemergut et al., 2001). The role of RCC1 in releasing sequestered proteins is 
well studied in microtubule assembly. Proteins involved in microtubule nucleation, 
including NuMA and TPX2, are sequestered by importins. Upon release by RCC1-
generated Ran-GTP, these and other proteins stabilize microtubules to form the mitotic 
spindle(Gruss et al., 2001; Nachury et al., 2001; Wiese et al., 2001). Although well 
documented in microtubule assembly, RCC1 mediated regulation of chromatin binding 
proteins is less well established. However, it was shown that a chromatin binding 
protein Kid is sequestered in the cytoplasm by importins and can only load onto mitotic 
chromatin following RCC1 mediated release(Tahara et al., 2008). In agreement with this 
model, HELLS contains a bipartite NLS, which could sequester the HELLS-CDCA7 
complex by importins until nucleosome dependent RCC1 signaling releases the 
complex. In the absence of nucleosomes, although HELLS-CDCA7 possesses DNA 
binding activity, importins would inhibit its DNA interaction. It is possible that other 
nucleosome dependent signaling pathways may be acting in an analogous manner. 
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CHAPTER 4: DISCUSSION AND PERSPECTIVE 
A unifying model for ICF syndrome 
At the onset of this project, there was no connection between HELLS and 
CDCA7 to ICF syndrome. Only mutations in DNMT3B and ZBTB24 were known to 
cause the disease, and the 30% of remaining patients had unidentified genetic causes. 
The generally accepted model was that DNMT3B mediated DNA methylation was 
defective in ICF due to reduced activity in DNMT3B enzymatic activity(Gowher and 
Jeltsch, 2002), however the role of ZBTB24 was entirely unknown. As the project 
progressed, it was reported that mutations in either HELLS or CDCA7 lead to ICF 
syndrome(Thijssen et al., 2015), but just like ZBTB24, the molecular function of these 
proteins was entirely unclear. Importantly, HELLS had previously been shown to direct 
the DNA methylation activity of DNMT3B to repress transcription(Myant and Stancheva, 
2008), which naturally led to the hypothesis that HELLS (and potentially CDCA7 and 
ZBTB24) ICF mutations inhibit DNA methylation in a manner similar to DNMT3B ICF 
mutations. Indeed, somehow, HELLS, ZBTB24, and CDCA7 knockdown all lead to 
reduced DNA methylation in fibroblasts(Thijssen et al., 2015). Finally, it was shown that 
ZBTB24 is required for the expression of CDCA7(Wu et al., 2016), but how ZBTB24, 
CDCA7, and HELLS are functionally and molecularly related to DNMT3B was not 
established. 
The data presented in Chapter 3 lead to a unifying model for ICF syndrome, 
which relates all known proteins involved in the disease (DNMT3B, HELLS, CDCA7, 
and ZBTB24) (Figure 4-1). In my preferred model, all ICF patient mutations converge on 
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defects in DNA methylation. Specifically, I fill in the missing link between the ZBTB24-
CDCA7 and HELLS-DNMT3B axes. As HELLS requires CDCA7 for in vitro remodeling 
activity, I propose that the concerted action of HELLS-CDCA7 nucleosome remodeling 
at juxtacentromeric heterochromatin facilitates DNMT3B mediated DNA methylation. 
Combined with the knowledge that ZBTB24 is required for CDCA7 expression(Wu et al., 
2016), I now provide a model for ICF syndrome, which explains all known ICF patient 
mutations at a high level. Furthermore, I specifically uncovered how CDCA7 ICF patient 
mutations inhibit recruitment of the HELLS-CDCA7 complex to chromatin, which would 
disrupt the DNA methylation pathway. Although this model explains how all known ICF 
causative proteins lead to defects in DNA methylation, the largest gap in the model is 
how reduced DNA methylation leads to the various ICF syndrome symptoms. 
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Figure 4-1. A unified model for ICF syndrome that converges on DNA methylation 
defects. 
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Consistent with my model, many HELLS ICF patient mutations are predicted to 
create a null protein, either by frameshift or by point mutation in the conserved ATPase 
domain, which is expected to abrogate its remodeling activity. However, two mutations 
have been identified that map to the C-terminal domain downstream of the ATPase 
domain(Thijssen et al., 2015). These mutations may indicate that this domain plays an 
important unknown role in mediating DNA methylation. As the core ATPase domain of 
nucleosome remodeler proteins is thought to be able to remodel nucleosomes even in 
the absence of the flanking domains(Clapier and Cairns, 2012), HELLS C-terminal 
domain may be required for auxiliary functions. For example, mutations in this domain 
may abrogate CDCA7 or DNMT3B interaction. Alternatively, this domain may be 
important for targeting HELLS-CDCA7 to specific genomic loci such as juxtacentromeric 
heterochromatin. Therefore, engineering these C-terminal mutations into HELLS could 
be useful for dissecting the mechanism of HELLS activity. 
In this model, the sole role of ZBTB24 is to provide CDCA7 to the cell. Unlike the 
other ICF proteins that mostly contain patient mutations in a single domain, ICF 
mutations have been found throughout ZBTB24. At present, only the deletion of a large 
domain within ZBTB24 (containing the BTB domain, AT hook, and a portion of the zinc 
finger domain) has been shown to result in reduced CDCA7 expression. As nothing is 
known about the function and mechanism of ZBTB24 action, studying individual ICF 
patient mutations within ZBTB24 could be a useful way to access the function of each 
domain within ZBTB24 and parse its various activities. For example, the BTB domain is 
speculated to facilitate dimerization of the protein, however this has not been 
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experimentally tested. Engineering ICF patient mutation V68 or H132, which maps to 
the BTB domain of ZBTB24 could be used to test this hypothesis. Similar approaches 
could be used to study the AT-hook and zinc finger domains, both of which have 
unknown functions with corresponding ICF patient mutations. 
An alternative model for ICF syndrome 
Here, I propose an alternative model for ICF syndrome. In contrast to my 
previous model (Figure 4-1) which converged on defects in DNA methylation, this model 
converges on defective remodeling of juxtacentromeric nucleosomes (Figure 4-2). 
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Figure 4-2. An alternative model for ICF syndrome that converges on nucleosome 
remodeling. The HELLS-CDCA7 remodeling complex can either require DNA 
methylation for remodeling activity (top) or chromatin recruitment (bottom).  
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Nucleosome remodelers make multiple contacts with DNA within the 
nucleosome(Farnung et al., 2017), therefore it is conceivable that the HELLS-CDCA7 
remodeling complex is regulated by DNA methylation. Perhaps DNA methylation 
enhances the remodeling activity of HELLS-CDCA7, or facilitates the physiological 
targeting of the complex to juxtacentromeric heterochromatin. Therefore, defective 
DNMT3B mediated DNA methylation could result in reduced HELLS-CDCA7 mediated 
nucleosome remodeling directly, or indirectly via reduced chromatin localization. 
Likewise, ZBTB24 mutations would result in decreased CDCA7 expression, and 
reduced targeting of the complex to methylated loci. Analogous to the previous model, 
this model does not explain how defective juxtacentromeric nucleosome remodeling 
results in ICF syndrome symptoms. 
There is precedence for nucleosome remodeling to be affected by DNA 
methylation. In the most well studied case, the nucleosome remodeler Mi-2 associates 
with MBD2(Le Guezennec et al., 2006), which specifically recognizes methylated 
DNA(Hendrich and Bird, 1998). It is thought that MBD2 directs the remodeling activity of 
Mi-2 to methylated promoters to facilitate gene silencing(Becker and Workman, 2013). 
Interestingly, Mi-2 can be alternatively associated with MBD3(Le Guezennec et al., 
2006), which only binds unmethylated DNA.  These data suggest that the complex is 
differently target to genomic context by auxiliary subunits that recognize DNA 
methylation, or lack thereof. This precedence supports that CDCA7-HELLS may be 
specifically targeted to and remodel methylated juxtacentromeric heterochromatin. 
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Multiple lines of evidence favor the “DNA methylation defect” (Figure 4-1) model 
over this “nucleosome remodeling defect” (Figure 4-2) model for ICF syndrome. The 
biochemical properties of HELLS and DDM1 (A. thaliana HELLS) are similar (see 
below) and the ATPase activity of DDM1 is unaffected by DNA methylation(Brzeski and 
Jerzmanowski, 2003). However, the nucleosome sliding activity has not been explicitly 
tested. Additionally, in my remodeling experiments (Figure 3-10), HELLS-CDCA7 shows 
robust sliding activity on unmethylated DNA, while the proposed model converging on 
nucleosome remodeling defects would be consistent with minimal sliding activity on 
unmethylated DNA. A direct comparison of the nucleosome sliding kinetics on 
unmethylated vs. methylated DNA would be required to cleanly address this 
discrepancy though. Moreover, this nucleosome remodeling defect model is 
inconsistent with the observations that patients with defective ZBTB24, HELLS, and 
CDCA7 also show reduced DNA methylation at juxtacentromeric heterochromatin, 
which would not be expected if HELLS-CDCA7 remodeling is downstream of DNMT3B 
mediated DNA methylation. Although, it is possible that a methylation-remodeling 
feedback loop could result in these methylation defect. Finally, this model contradicts 
preliminary experiments that HELLS-CDCA7 is specifically recruited to DNA beads 
coated with unmethylated DNA instead of methylated DNA in Xenopus extracts, 
whereas the model predicts the opposite (J. Xue, personal communication). Because of 
these inconsistencies, I favor the original model where all ICF mutations converge on 
DNA methylation, however, more experiments are required to definitively test this. 
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HELLS regulation by CDCA7, CDCA7L and CDCA7e 
Given that Arabidopsis HELLS can remodel nucleosomes in vitro without any 
accessory factors, it raises the question of why vertebrate HELLS requires CDCA7. 
Here, I propose that CDCA7 paralogs act as a mechanism to differentially regulate 
HELLS. 
Auxiliary proteins are well known to alter the biochemical directionality of 
nucleosome remodeling enzymes. In the most thoroughly studied example, Snf2h was 
shown to end-position nucleosomes when in complex with RSF, but center-position 
nucleosomes when in complex with BAZ1A(Oppikofer et al., 2017). In a similar manner, 
while CDCA7e efficiently slides nucleosomes to the end of DNA fragments (Figure 3-
10), HELLS-CDCA7 or HELLS-CDCA7L could center-position or randomize 
nucleosomes on DNA fragments. In contrast to HELLS-CDCA7e, DDM1 effectively 
center-positions mononucleosome substrates, highlighting the potential plasticity in the 
biochemical functionality of HELLS. Unfortunately, no convincing hypothesis has been 
proposed to explain how these biochemical differences could manifest into different 
biological functions. 
In addition to enzymatic regulation, CDCA7 paralogs may differentially target 
HELLS to different genomic loci. I hypothesize that the CDCA7 paralogs recruit HELLS 
to juxtacentromeric heterochromatin, since CDCA7 ICF mutations result in reduced 
juxtacentromeric DNA methylation. However, HELLS is localized to other loci 
throughout the genome including LINE-1 elements(Ren et al., 2015) and promoters(von 
Eyss et al., 2012), which could be due to either CDCA7 or CDCA7L mediated targeting. 
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This targeting specialization is in agreement with CDCA7 being the chromatin-binding 
module of the HELLS-CDCA7 complex. By recognizing different DNA sequences, DNA 
methylation states, or nucleosome modifications, CDCA7 and CDCA7L could 
functionally specialize to recruit HELLS to different genomic loci. This would be 
analogous to ISWI, which uses auxiliary proteins to target the complex to differentially 
modified nucleosomes. Alternatively, CDCA7 may be a specificity factor that recruits 
HELLS to specific histone variants, similarly to DAXX within the ATRX-DAXX complex. 
To get a complete picture, a recently developed high-throughput assay(Dann et al., 
2017) could be used to determine how HELLS-CDCA7, CDCA7L and CDCA7e are 
affected by the underlying chromatin modifications. 
By specifically knocking out CDCA7 or CDCA7L and performing ChIP-seq on 
HELLS, the individual contribution of each CDCA7 paralog could be determined. Based 
on RNA-seq analysis, CDCA7 and CDCA7L are differentially expressed in a tissue-
dependent manner. Therefore, it may be required to perform these CDCA7/CDCA7L 
knockdown HELLS ChIP-seq experiments in a variety of cell lines to get a complete 
understanding of the differences between paralogs. 
The similarities and differences between DDM1 and HELLS-CDCA7 
Comparing and contrasting DDM1 and HELLS-CDCA7 may lead to important 
insights into the function and regulation of these proteins. In many regards, DDM1 and 
HELLS are biochemically and functionally similar. Although HELLS requires 
nucleosomes and CDCA7 for chromatin interaction in physiological extracts, purified 
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HELLS and DDM1 both interact with naked DNA and nucleosomes in vitro (Figure 3-7 
and (Brzeski and Jerzmanowski, 2003)). In addition to binding DNA, purified HELLS and 
DDM1 possess naked DNA and nucleosome dependent ATPase activity in the absence 
of any auxiliary proteins (Figure 3-11 and (Brzeski and Jerzmanowski, 2003)). One 
striking difference between their nucleosome remodeling activities is that DDM1 prefers 
to mobilize end-positioned nucleosomes to the center of DNA fragments, while HELLS-
CDCA7 does the opposite (Figure 3-10 and (Brzeski and Jerzmanowski, 2003)). Finally, 
DDM1 and HELLS are functionally similar as both are required for facilitating cytosine 
methylation(Lyons and Zilberman, 2017). 
Since vertebrate HELLS and A. thaliana DDM1 are well conserved (in sequence 
and function), it is surprising that DDM1 itself can remodel nucleosomes while HELLS 
requires CDCA7 for remodeling. While examining the sequence structure, I noticed that 
vertebrate HELLS contains a 59 amino acid insert between its two ATPase domains, 
not present in DDM1. Interestingly, this insert is conserved in opisthokonts, but is 
lacking in plants (Figure 4-3). This “split-ATPase” structure in vertebrate HELLS is 
reminiscent of a distantly related nucleosome remodeler INO80. INO80 has a 281 
amino acid insertion between its ATPase domains, and similar to HELLS, is thought to 
be unable to remodel nucleosomes on its own. Instead INO80 is proposed to require 
actin, Arp4, Arp5, Arp8, Ies2, Ies6, RUVBL1, and RUVBL2 for remodeling(Willhoft et al., 
2016). Perhaps insertions between the ATPase domains are a common mechanism to 
render nucleosome remodelers dependent on auxiliary proteins. 
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Figure 4-3. Phylogeny of HELLS. Dendrogram, whether HELLS remodels and 
contains a “split-ATPase” insert is shown for the indicated species. 
Species Contains	
Insert?
Remodels? GenBank Accession
A.	thaliana Plant No Yes OAO91248.1
C.	sativa Plant No ? XP_010444738.1
C.	eustigma Algae No ? GAX75958.1
S.	cerevisiae Yeast Yes ? AJU35866.1
M.	musculus Animal Yes No AAI00395.1
X. laevis Animal Yes No AAH97562.1
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I wondered if perhaps DDM1 possesses intrinsic nucleosome sliding activity 
because it is a hybrid of HELLS-CDCA7 in a single polypeptide. Indeed, Arabidopsis 
DDM1 contains a 116 amino acid stretch with low homology to CDCA7 (24% identity) 
(Figure 4-4). This homologous stretch maps to the zinc finger domain of CDCA7, and 
occurs between the two ATPase domains of DDM1. Although the homology maps to the 
zinc finger domain of CDCA7, the CXXC motifs are largely divergent between CDCA7 
and DDM1, suggesting that the domain is not a bona fide zinc finger domain in DDM1. 
Interestingly, vertebrate HELLS also contains the homology to CDCA7, but the CDCA7 
homology domain is disrupted by the previously described 59 amino acid insertion 
(Figure 4-4). I speculate that by disrupting the CDCA7 homology domain in vertebrate 
HELLS, the remodeler became dependent on an external CDCA7, which could allow 
specialization by different CDCA7 paralogs (CDCA7, CDCA7L, CDCA7e). It would be 
interesting to test if vertebrate HELLS remodeling activity could be rescued by removing 
the 59 amino acid disruption within its CDCA7 homology domain. Alternatively, it would 
be interesting to test if Arabidopsis HELLS could be made dependent on external 
CDCA7 by disrupting its CDCA7 homology domain with the vertebrate HELLS insert. 
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Figure 4-4. DDM1 contains homology to the CDCA7 zinc finger. Note how X. laevis 
HELLS also contains homology to CDCA7, however, it is interrupted by an insertion. 
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As DDM1 can remodel nucleosomes in the absence of CDCA7, I was surprised 
to find that the A. thaliana genome contains proteins harboring homology to the CDCA7 
zinc finger (identified by reciprocal blast search). I speculate that DDM1 with the CDCA7 
zinc finger homology domain may be able to remodel nucleosomes in vitro, but may not 
be targeted to correct genomic loci in vivo. This would be reminiscent of HELLS-CDCA7 
with CDCA7 harboring ICF mutations (Figure 3-16),  has remodeling activity 
comparable to wild type CDCA7 but cannot associate with chromatin under 
physiological conditions. DDM1 could likewise utilize CDCA7 like proteins for genomic 
targeting and chromatin association. As there are at least four proteins in the A. thaliana 
genome that contain the CDCA7 zinc finger domain (Figure 4-5), these proteins may 
differentially target DDM1 to different genomic loci in distinct contexts. This could be 
tested by performing ChIP-seq on DDM1 in the absence of the various CDCA7 
paralogs. 
Alternatively, DDM1 was initially noted as a relatively weak remodeler, only able 
to mobilize 50% of nucleosomes in a remodeling assay(Brzeski and Jerzmanowski, 
2003). Therefore, DDM1 may be reliant on CDCA7 like proteins for robust remodeling 
activity in vitro and in vivo. 
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Figure 4-5. Arabidopsis proteins containing the CDCA7 CXXC zinc finger motif. 
The CXXC motifs are underlined. 
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Outlook: Open Questions in ICF syndrome 
In the previous paragraphs, I outlined how all known ICF mutations may lead to 
defects in DNA methylation. Currently, the major question regarding ICF syndrome is 
how the patient symptoms, including immunodeficiency and centromere instability, are 
caused by defects in DNA methylation. Here I speculate that the causes of ICF patient 
symptoms may arise from unresolved DNA damage. 
As previously discussed, ICF patients have stretched juxtacentromeric 
heterochromatin on chromosomes 1, 9, and 16 in lymphocytes. However, ICF patients 
do not have reported chromosomal abnormalities in fibroblasts(Maraschio et al., 1989), 
suggesting that the chromosomal defect may be specific to lymphocytes and may be 
causative to the immunodeficiency symptoms. As CDCA7 ICF mutations caused mitotic 
chromosomal abnormalities in Xenopus egg extracts (Figure 3-17), I looked for 
similarities between the Xenopus egg and lymphocytes. Two similarities were apparent: 
shortened cell cycle length and suppressed DNA damage response. Both the frog egg 
(30-80 min (Morgan, 2007)) and stimulated lymphocytes (10.5 hr (Auf der Maur and 
Berlincourt-Bohni, 1979)) have relatively short cell cycles. Additionally, the ATR-
mediated DNA damage response is attenuated in the frog egg prior to the mid-blastula 
transition(Peng et al., 2008) as well as in lymphocytes(Jones et al., 2004). These 
unique similarities lead me to a model whereby the chromosome defects associated 
with ICF arise from DNA damage in the shortened cell cycle that remains unresolved as 
the cells enter mitosis. Accelerated cell cycles coupled to suppressed resolution of DNA 
damage could lead to accumulation of genetic defects and ultimately lead to cell death. 
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While highly speculative, a few lines of evidence support this hypothesis. First, 
although most ICF patients have agammaglobulinaemia, all ICF patients have B cells, 
suggesting that late stage lymphocyte differentiation is defective, which is consistent 
with the hypothesized accumulating DNA damage leading to cell death. Similarly, ICF 
patients have an increased frequency of mitotic defects such as anaphase bridges in 
their cultured lymphoblastoid cell lines(Gisselsson et al., 2005),  suggests that there 
may be unresolved DNA damage in these cells. Furthermore, ICF proteins have been 
shown to be involved in the DNA damage response. HELLS has previously been shown 
to be required for efficient repair of DNA double strand breaks via promoting gamma-
H2AX phosphorylation(Burrage et al., 2012). Additionally, although not understood why, 
global genomic DNA demethylation results in a variety of DNA damage associated with 
chromosomal defects including increased mutation rates(Chen et al., 1998), 
chromosome instability(Chen et al., 2007), chromosome duplications(Gaudet et al., 
2003) and apoptosis(Jackson-Grusby et al., 2001). These reports highlight how ICF 
patients may be susceptible to DNA damage, and unresolved DNA damage ultimately 
leading to cell death in lymphocytes could manifest with symptoms associated with ICF 
such as agammaglobulinaemia and immunodeficiency. 
To test this hypothesis, it would be useful to know if ATR depletion could 
recapitulate ICF-like chromosomal defects in non-lymphocytes. In agreement with this 
idea, ATR inhibition with caffeine can cause chromosomal abnormalities in ICF patient 
fibroblasts(Maraschio et al., 1989), however, a more specific ATR deletion/inhibition will 
need to be performed to confirm the role of ATR in the process. Additionally, it would be 
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interesting to see if reintroducing ATR in lymphocytes could suppress the chromosomal 
abnormalities in ICF patient cells. As an alternative approach, since ATR is suppressed 
in the Xenopus egg prior to the mid-blastula transition, it would be interesting to 
compare chromosomes in CDCA7 depleted extract made from pre- and post-MBT 
Xenopus embryos. The prediction would be that post-MBT, activated ATR would 
resolve the DNA damage resulting in phenotypically normal chromosomes, while pre-
MBT extract would show stretched and fragile chromosomes. 
In summary, this work connects many previously disparate observations about 
ICF syndrome into a unified theory, and points a way forward in studying the rare 
disease. Much of this work was published in (Jenness et al., 2018; Zierhut et al., 2014) 
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CHAPTER 5: MATERIALS AND METHODS 
Biochemistry 
Cloning 
Codon optimized Xenopus HELLS-TEV-CBP (Thermo GeneArt Strings) was 
Gibson assembled into pRS306G(Devbhandari et al., 2017) yeast expression plasmid 
containing PGK1 3’ UTR. Xenopus embryonic CDCA7e (GE EXL1051-205982802) was 
Gibson assembled into pMAL (NEB). CDCA7 (accession no. BC130191), CDCA7L 
(accession no. BC126014), and CDCA7e were Gibson assembled with an N-terminal 6x 
MYC tag into pCS2. HELLS (accession no. NM_001092973.1) was Gibson assembled 
with a C-terminal GFP tag into pCS2. 
Protein purification 
MBP-CDCA7-HIS was expressed in E. coli at 16 °C overnight. Cells were 
centrifuged, resuspended in lysis buffer (1X PBS, 150 mM NaCl, 4 mM 2-
mercaptoethanol, 20 mM imidazole, 0.1% Triton X-100, 100 µM ZnSO4, 1 mM PMSF,
0.25 mg/ml lysozyme, 5 µg/ml DNaseI, 10 μg/ml leupeptin, 10 g/ml pepstatin and 10 
μg/ml chymostatin, pH 7.8), and lysed by sonication. Lysate was centrifuged (Sorvall 
SS34 rotor, 14,000 r.p.m.) for 30 min at 4 °C, and supernatant was incubated with 2 ml 
Ni-NTA agarose (Qiagen) for 1 h at 4 °C. Resin was washed 3 times with 20 ml wash 
buffer (1X PBS, 150 mM NaCl, 4 mM 2-mercaptoethanol, 100 µM ZnSO4, pH 7.8)
supplemented with 20 mM imidazole, 10 mM ATP, and 2.5 mM MgCl2. Protein was 
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eluted with wash buffer containing 400 mM imidazole. Eluate was incubated with 5 ml 
amylose resin (New England BioLabs) for 1 h at 4 °C. Amylose resin was washed 3 
times with 20 ml wash buffer, and MBP-CDCA7e was eluted with wash containing 20 
mM maltose. Purifed MBP-CDCA7e was dialyzed in buffer (1X PBS, 150 mM NaCl, 4 
mM 2-mercaptoethanol, 100 µM ZnSO4, pH 7.8) and concentrated via spin column 
(Amicon). 
To purify HELLS-CBP, S. cerevisiae containing pRS306G(Devbhandari et al., 
2017) containing HELLS-CBP were grown in YP-raffinose at 30 °C to 1.3 x 107 cells/ml. 
Protein expression was induced by adding galactose (2% final) and incubating for 4 h. 
Cells were centrifuged, washed once with buffer A (25 mM HEPES, 1 M sorbitol, pH 
7.6), and once with buffer B (45 mM HEPES, 0.02% Triton X-100, 10% glycerol, 5 mM 
Mg (OAc)2, 0.1 M K-glutamate, pH 7.6). Cells were resuspended in 0.5 volumes buffer B 
with supplemented with 1 mM DTT, 10 μg/ml leupeptin, 10 μg/ml pepstatin and 10 
μg/ml chymostatin. Cells were frozen dropwise in liquid N2 and ground in a cryogenic 
grinding mill (SPEX). Cell powder was resuspended in buffer C (10 mM HEPES, 300 
mM KCl, 10 mM 2-mercaptoethanol, pH 8.0) containing 2 mM CaCl2, and centrifuged 
(SS-34 rotor, 19,000 r.p.m.) for 30 min at 4 °C. Supernatant was incubated with 5 ml 
calmodulin resin for 1 h at 4 °C. Resin was washed 5 times with 20 ml buffer C 
containing 2 mM CaCl2, and protein was eluted with buffer C, supplemented with 10 mM 
EDTA. Eluate was loaded on a heparin column (GE), washed with buffer C, and eluted 
with buffer C containing 500 mM KCl. Purified HELLS-CBP was concentrated by 
covering HELLS-containing dialysis membrane with sucrose for 1 h at 4 °C.  
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Histones were purified as described(Zierhut et al., 2014). H2B, H2A, H3.2 and 
H4 were individually expressed in E. coli for 4 h at 37 °C. Cells were centrifuged, 
washed once with lysis buffer (50 mM Tris-Cl, 100 mM NaCl, 10 mM imidazole, 10 
mM 2-mercaptoethanol, 0.25 mg/ml lysozyme, 5 µg/ml DNaseI, 10 μg/ml leupeptin, 10 
μg/ml pepstatin and 10 μg/ml chymostatin, pH 8.0) and resuspended in 30 ml lysis 
buffer. Cells were lysed by sonication and centrifuged (SS34, 20,000 g) for 15 min at 4 
°C. Inclusion bodies were rinsed with wash buffer (50 mM Tris-Cl, 100 mM NaCl, 10 
mM imidazole, 10 mM 2-mercaptoethanol, pH 8.0), and resuspended in 15 ml wash 
buffer with 1% Triton X-100. Inclusion bodies were centrifuged (SS34, 13,000 r.p.m.), 
washed twice with wash buffer, and centrifuged again. Pellets were resuspended in 1 ml 
DMSO, diluted in 25 ml D500 buffer (6 M Guanidine HCl, 500 mM NaCl, 50 mM Tric-Cl, 
5 mM 2-mercaptoethanol, 7.5 mM imidazole, pH 8.0), and rotated overnight at room 
temperature. Mixture was centrifuged (SS34, 30,000 r.p.m.) for 20 min at 4 °C. H2B, 
H3, and H4 were further purified by incubation with 1.5 ml Ni-NTA agarose resin for 90 
min at room temperature. Resin was washed 5 times with 20 ml D500 and 3 times with 
20 ml D1000 (6 M Guanidine HCl, 1 M NaCl, 50 mM Tric-Cl, 5 mM 2-mercaptoethanol, 
7.5 mM imidazole, pH 8.0). Proteins were eluted with 5 ml elution buffer (6 M Guanidine 
HCl, 1 M NaCl, 50 mM Tric-Cl, 5 mM 2-mercaptoethanol, 300 mM imidazole, pH 7.5). 
H3 harboring K9 trimethylation was generated by protein semisynthesis as 
described(Muller et al., 2016) 
H3-H4 tetramers and H2A-H2B dimers were refolded as described(Zierhut et al., 
2014). Each histone (45 µM) was added to 4.5 ml final volume D500. Histones were 
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dialyzed stepwise in dialysis buffer (20 mM MOPS, 500 mM EDTA, 1 mM EDTA, 4 mM 
DTT, pH 7.0) containing 10%, 5%, and 2.5% glycerol each for 4 h. Refolded histones 
were centrifuged, and the supernatant was incubated with 0.02 mg/ml TEV protease 
overnight at 16 °C. Refolded histones were purified by size exclusion chromatography 
(GE Healthcare HiLoad 16/60 Superdex 75). 
SNF2h was a gift of N. Gamarra and G. Narlikar. 
Nucleosome array and mononucleosome purification 
19x601 Nucleosome arrays were prepared as described(Zierhut et al., 2014). 
Nineteen 601-positioning sequences separated by 53 bp linking DNA were digested 
from pAS696 with HaeII, DraI, EcoRI and XbaI. The array was purified by PEG 
precipitation, and both ends were biotinylated by Klenow (NEB) fill-in with biotin-16-
dUTP (ChemCyte). 19x601 arrays were purified from free nucleotides by Illustra Nick 
columns (GE Healthcare). 19x601 nucleosome arrays were prepared by gradient salt 
dialysis of H3-H4 tetramers, H2A-H2B dimers onto the DNA array. The quality of the 
array was verified by AvaI digest, which cuts between 601 monomers, resulting in pure 
mono-nucleosomes when resolved on a native polyacrylamide gel. Nucleosome arrays 
(900 ng) were coupled to 3 µL M-280 streptavidin Dynabeads (ThermoFisher) in bead 
coupling buffer (2.5% polyvinyl alcohol, 150 mM NaCl, 50 mM Tris-Cl, 0.25 mM EDTA, 
0.05% Triton X-100, pH 8.0) at room temperature for 3 h. When coupling naked 19x601 
DNA to Dynabeads, bead-coupling buffer contained 1.5 M NaCl. Mononucleosomes 
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were prepared as above, but with digesting AvaI arrays and PEG purification prior to 
salt dialysis. 
Antibodies 
A summary of all custom antibodies generated in this study is summarized (Table 
5-1). For antibody production, C-terminal or N-terminal peptides of Xenopus proteins 
were synthesized (Rockefeller University Proteomics Resource Center). Peptides were 
coupled to keyhole limpet hemocyanin according to manufactures’ protocol 
(ThermoFisher) and used for rabbit immunization (Cocalico Biologicals). Antibodies 
were affinity purified from serum using the same peptides coupled to SulfoLink resin 
(ThermoFisher) according to manufacturers’ protocol. All other antibodies used 
throughout this study and their sources are listed (Table 5-2). 
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Table 5-1. Custom antibodies generated in this study. 
Protein Antigen Western 
Blot 
Immuno-
depletion 
IF Identifier 
xHELLS CQGVFKVVDSTEVTVS Yes Yes Yes RU1995 
xHELLS MPVGQSSAEQVSPAPC Yes Yes No RU1996 
xCDCA7e CLNSLRNTKDEDSDGS Yes Yes No RU1998 
xH1M CGAPVKAGKKGKKVTN Yes Yes Yes RU1974 
xHP1-gamma MGKKQNGKSKKVEEAC Yes Yes ? RU1985 
xSPT16 CKGHAPLPNPSKKRKK Yes Yes ? RU1983 
Custom antibodies generated in this study and whether they have specific reactivity by 
Western blot, immunodepletion, or immunofluorescence (IF). 
	158 
Table 5-2. Published antibodies used in this study 
Antibody Reference 
Aurora B (Kelly et al., 2007) 
CDCA7 RU1998 
Dasra (Sampath et al., 2004) 
DNMT1 (Nishiyama et al., 2013) 
GFP Thermo A11122 
H1M RU1974 
H2B Abcam Ab1790 
H3 Abcam Ab1791 
H3T3ph Millipore 07-424 
H3K9me3** (Chandra et al., 2012) 
H3S10ph* H. Kimura gift, unpublished 
H4K12Ac (Hayashi-Takanaka et al., 2015) 
HELLS RU1995 
HIRA (Ray-Gallet et al., 2002) 
INCENP (Sampath et al., 2004) 
ISWI (MacCallum et al., 2002) 
MBP NEB E8032 
MCM7 (Walter and Newport, 2000) 
MYC Millipore 4A6 
Op18 (Budde et al., 2001) 
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Phospho-Aurora B Cell signaling 2914 
Phospho-CDK substrate Cell signaling 2324 
Plx1 (Kelly et al., 2007) 
RCC1 (Nachury et al., 2001) 
Spt16 Cell signaling mAB 12191 
Survivin (Tseng et al., 2010) 
Topoisomerase II (Hirano and Mitchison, 1993) 
XCAP-G (Zierhut et al., 2014) 
Xkid (Funabiki and Murray, 2000) 
Antibodies used in this study and their associated references. 
* H3S10 antibody (3-7C4) allows H3K9 mono-, di-, tri-methylation and H3K9 acetylation
** H3K9me3 antibody (2F3) is occluded by H3S10ph. 
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Immunoprecipitations 
For in vitro co-immunoprecipitation experiments, 2.5 µg anti-MBP (NEB E8032) 
or preimmune mouse IgG (Sigma-Aldrich) were coupled to 10 ul Protein A Dynabeads 
for 1 h at room temperature. Beads were recovered on a magnet and washed 
extensively in sperm dilution buffer. Beads were resuspended in sperm dilution buffer 
with 0.05% Triton X-100 and 200 nM indicated proteins. Samples were agitated for 30 
min at 20 °C. Beads were recovered on a magnet, washed three times with sperm 
dilution buffer with 0.05% Triton X-100. Beads were resuspended in SDS-PAGE buffer, 
resolved by gel electrophoresis, and stained with GelCode Blue (ThermoFisher). 
To test MBP-CDCA7e ICF mutant binding to HELLS-GFP, HELLS-GFP or GFP 
was expressed in the TnT Coupled Reticulocyte Lysate System (Promega) according to 
the manufacturer’s instructions. TnT reaction was diluted 1:5 in binding buffer (10 mM 
HEPES, 100 mM NaCl, 0.025% Triton X-100, 0.25 mM TCEP, pH 7.8) containing 100 
nM CDCA7e, and incubated for 20 min at 20 °C. To each sample, 10 µl anti-MBP 
coated protein A beads were added, and the sample incubated for 20 min at 20 °C. 
Beads were recovered, washed and resolved by gel electrophoresis as before. Gel was 
stained with GelCode Blue (Thermo Fisher), dried, and exposed on a PhosphorImager 
screen. 
Chromatin interactions 
To assay CDCA7e chromatin binding in vitro, 3 µl 19x601 DNA or nucleosome 
beads were incubated in 50 µl binding buffer (20 mM HEPES, 200 mM NaCl, 0.05% 
	161 
Triton X-100, 0.5 mM TCEP, pH 7.8) containing 1 µM of MBP-CDCA7e for 30 min at 20 
°C. Beads were collected on a magnet and washed 3 times with binding buffer. Beads 
were resuspended in SDS-PAGE buffer, boiled, and collected on a magnet. The 
supernatant resolved by gel electrophoresis and stained with GelCode Blue. To assay 
HELLS DNA binding, 3 µl DNA beads were incubated in 20 µl sperm dilution buffer with 
0.05% Triton X-100 and 1 µM protein for 45 min at room temperature. Beads were 
collected on a magnet and washed 3 times with sperm dilution buffer with 0.05% Triton 
X-100. Beads were resuspended in SDS-PAGE buffer, boiled, and collected on a 
magnet. The supernatant resolved by gel electrophoresis and stained with GelCode 
Blue. To assay recombinant topoisomerase II chromatin binding in vitro, nucleosome 
beads, DNA beads or uncoupled beads were incubated in binding buffer (10 mM Tris, 
pH 7.5, 150 mM NaCl, 0.05% Triton X-100) containing 1.6 μM recombinant Xenopus 
topoisomerase II (a gift from Y. Azuma) and 1 ng/μl BSA for 60 min at 20 °C with 
vigorous agitation. Beads were recovered on a magnet and washed three times in 
binding buffer. Bound proteins were eluted from the beads by incubation with SDS 
sample buffer. 
ATPase assays 
For ATPase assays, 100 nM protein was added to 10 µl ATPase buffer (25 mM 
HEPES, 60 mM KCl, 4% glycerol, 4 mM MgCl2, 1 mM cold ATP, 0.1 µCi/µL g-33P ATP,
pH 7.6) containing 40 ng/µl DNA or nucleosomes, and incubated at 16 °C. At the 
indicated times, 1 µl reaction was spotted on PEI a cellulose TLC plate and dried. Plates 
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were separated in 1.2 M KH2PO4, pH 3.8. Plates were dried and exposed on a 
PhosphorImager screen. 
Nucleosome remodeling assays 
To assay nucleosome remodeling by restriction enzyme accessibility, 
mononucleosomes were positioned on a 601 sequence with a PstI site engineered 15 
bp into the nucleosome and 20 bp flanking DNA on each end (a gift of N. Gamarra and 
G. Narlikar). Nucleosomes (15 nM) were added to remodeling buffer (6.5 mM HEPES, 2 
mM ATP-Mg, 5 mM MgCl2, 70 mM KCl, 0.02% Triton X-100, 3 U/µl PstI (NEB), pH 7.5)
containing 100 nM HELLS, CDCA7e or SNF2h (a gift of N. Gamarra and G. Narlikar). 
Where indicated, 15 or 1.5 mM remodeling proteins were substituted. Reactions 
incubated at 25 °C. At the indicated times, 5 µl remodeling reaction was added to 5 µl 
stop buffer (20 mM Tris, 70 mM EDTA, 2% SDS, 20% glycerol, 0.2 mg/ml bromophenol 
blue, 3.3 mg/ml Proteinase K, pH 7.5) and incubated at 50 °C for 20 min. 5 µl of each 
sample was resolved on a 10% polyacrylamide gel in 1X TBE at 150 V for 3 h and 
stained with SYBR gold for 30 min. Where indicated, a similar procedure was performed 
using a mononucleosome on a 601 sequence containing 34 bp and 23 bp flanking DNA 
on the 5’ and 3’ ends respectively and MspI restriction enzyme (NEB). To assay mobility 
of end positioned nucleosomes, mononucleosomes were positioned on a 601 sequence 
containing 60 bp 3’ flanking DNA, and the protocol was repeated using HaeIII in place of 
PstI. 
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To assay nucleosome remodeling by native gel, aforementioned center-
positioned or end-positioned mononucleosomes (20 nM) were added to remodeling 
buffer (12 mM HEPES, 2 mM ATP-Mg, 3 mM MgCl2, 0.02% Triton X-100, 70 mM KCl, 
11% glycerol, pH 7.5) containing 100 nM HELLS-CBP, MBP-CDCA7e or SNF2h (100 
nM), and incubated at room temperature. At the indicated times, 5 µl remodeling 
reaction was added to 5 µL stop solution (0.7 mg/ml plasmid DNA, 30 mM ADP, 20% 
glycerol). 5 µl of each sample was resolved on a 5% polyacrylamide gel in 0.5X TBE at 
80V for 3 h and stained with SYBR gold. 
Western blotting and immunofluorescence 
All Western blotting and immunofluorescence was performed at room 
temperature. For all Western blots, proteins were transferred to a nitrocellulose 
membrane (GE) and blocked in Blocking Buffer (4% milk, 1x PBS, 0.1% azide) for 30 
min. Membranes were coated in primary antibodies diluted in Abdil (10 mM Tris, 150 
mM NaCl, 2 % BSA, 0.1 % Triton X-100, 0.1% azide, pH 7.4) and rocked for 1 h. All 
primary antibodies were used at 1 µg/mL except for anti-phospho-Aurora B (1:200), 
anti-MCM7 (1:9000), anti-survivin (12 µg/ml), Plx1 (0.2 µg/mL) and anti-Aurora B (5 
µg/ml). Membranes were washed three times with PBS-T (1X PBS, 0.05% Tween-20). 
Primary antibodies were detected by coating membranes with LI-COR IRDye secondary 
antibody (1:15,000 in Abdil) for an hour. Membranes were washed as before three times 
with PBS-T, once with PBS, and subsequently imaged and quantified on an Odyssey 
Infrared Imaging System. 
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For all immunofluorescence experiments, coverslips were blocked in 500 µL 
Abdil overnight. Coverslips were incubated in primary antibody (50 µL) diluted in Abdil 
for 1 h. All primary antibodies were used at 1 µg/mL. Coverslips were washed three 
times with Abdil and incubated in secondary antibody (50 µL) diluted in Abdil. 
Secondary used were conjugated with Alexa Fluor 555 or Alexa Fluor 488 (Life 
Technologies) diluted 1:1000 in Abdil. Coverslips were washed three times in Abdil. For 
staining DNA, coverslips were incubated in Hoechst (0.5 µg/mL) or PicoGreen (1:500) 
diluted in Abdil for 30 min, and washed once with Abdil. Coverslips were mounted in 2 
µL Mounting Buffer (90% glycerol, 1xPBS) and sealed with nail polish.  
All microscopy was performed on a Delta Vision Spectris (Applied Precision) 
microscope. For maximum and average projections, Z-sections of 200 nM were 
collected over the entire depth of the sample. All image analysis was performed with 
ImageJ. To measure chromosome lengths, dashed lines were drawn down the center of 
each chromosome axis, and the distance was recorded. 
Protein alignment 
Protein alignment was performed with MacVector. Proteins were aligned using ClustalW 
with an open gap penalty of 10 and an extended gap penalty of 0.2. 
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Xenopus egg extracts 
Extract preparation and depletions 
CSF-arrested Xenopus laevis egg crude extracts were prepared as 
described(Murray, 1991). Extracts were kept on ice, and all extract experiments were 
performed at 20 °C unless specified. For experiments in interphase extract, CaCl2 was
added (0.3 mM final). Where indicated, Plx1 inhibitor BI2536 was used at 10 µM, and 
geminin was used at 200 nM. 
To immunodeplete HELLS, CDCA7e, Plx1, or the CPC in 50 µl extract, 25 µg 
anti-HELLS, anti-CDCA7e, or anti-INCENP antibody was coupled to 100 µl Protein A 
Dynabeads (ThermoFisher). INCENP antibody was crosslinked to the beads with BS3
(ThermoFisher), following manufacture’s protocol. Antibody beads were washed 
extensively in sperm dilution buffer (5 mM HEPES, 100 mM KCl, 150 mM sucrose, 1 
mM MgCl2, pH 8.0), split in half, and extract was depleted in two rounds at 4 °C, each
45 min. Beads were removed on a magnet. To deplete H1M, the previous depletion 
protocol was performed twice. To deplete DNMT1, 85 µL serum was coupled to 25 µL 
protein A beads as before and used to deplete 33 µL extract in three separate rounds. 
For all experiments, mock depletion was performed using purified preimmune rabbit IgG 
(Sigma-Aldrich). 
Histones H3-H4 were depleted as described(Zierhut et al., 2014). To deplete 50 
µl extract, 130 µg anti-H4K12ac antibody was coupled to 12.5 ul rProtein A sepharose 
(GE Healthcare). Extract was rotated with beads for 60 min at 4 °C and recovered. 
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Depleted extract was incubated with 8.5 µl fresh rProtein A sepharose to recover 
leached antibody for 35 min at 4 °C and recovered. 
Analysis of chromatin associated proteins 
Analysis of chromatin associated proteins was carried out as described(Zierhut et 
al., 2014). Nucleosome beads (0.15 µl/µl extract) were incubated in Xenopus egg 
extract for 2 h at 16 °C for MS experiments or 80 min at 20 °C for all other experiments, 
with flicking every 20 minutes. The extract was diluted with 10 volumes CSF-XB (10 mM 
HEPES, 100 mM KCl, 1 mM MgCl2, 50 mM sucrose, 5 mM EGTA, pH 8), and recovered 
on a magnet for 5 min at 4 °C. Beads were washed and recovered 3 times with 150 µl 
CSF-XB with 0.05% Triton X-100. Beads were resuspended in SDS-PAGE buffer and 
boiled. The beads were collected on a magnet and the supernatant resolved by gel 
electrophoresis. For mass spectrometry experiments, samples were run 1 cm into the 
gel. 
Mass spectrometry 
For MS analysis, standard trypsin digestion was performed followed by LC-
MS/MS on a Finnigan Orbitrap XL (Thermo Scientific) mass spectrometer. MS/MS data 
were extracted with Proteome Discoverer (Thermo Scientific) and queried against an 
mRNA derived X. laevis reference database(Wuhr et al., 2014) with Mascot 
(Matrixscience). This database was crucial, since the previously used NCBI database 
did not contain embryonic CDCA7e at the time. Mass tolerance of 20 p.p.m. peptide 
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precursor and 0.5 Da peptide fragments were used. Oxidized methionine, N-terminal 
acetylation and up to three missed cleavage sites were allowed. Proteome Discoverer 
(Thermo Scientific) was used to quantify protein abundance on chromatin. LC-MS 
peaks of each identified peptide were integrated, and isotope peaks for each peptide 
were summed to give the total peptide area. Protein abundance was calculated by 
averaging of the three greatest peptide signals for each protein. Experimental 
reproducibility of this procedure has been reported(Zierhut et al., 2014). 
Unsupervised clustering of mass spectrometry data was performed on the top 
70th percentile of chromatin associated proteins enriched over their extract 
concentration(Wuhr et al., 2014). Clustering was performed using the default HOPACH 
algorithm(Van der Laan and Pollard, 2003) using cosine angle as the distance metric.  
Entire clustering is shown in Figure A-11. 
Immunoprecipitation 
For co-immunoprecipitation from Xenopus egg extracts, anti-HELLS and anti-
CDCA7e antibodies (25 µg) were coupled to 100 µl Protein A Dynabeads for 1 h at 
room temperature. Antibodies were crosslinked to the beads with BS3, following 
manufacture’s protocol. Antibody-beads were washed extensively in sperm dilution 
buffer (5 mM HEPES, 100 mM KCl, 150 mM sucrose, 1 mM MgCl2, pH 8.0). 50 µl
extract was added to the beads and incubated on ice for 1 h with flicking every 20 min. 
The extract was diluted with 10 volumes CSF-XB (100 mM KCl, 1 mM MgCl2, 50 
mM sucrose, 5 mM EGTA and 10 mM HEPES, pH 8), and recovered on a magnet for 5 
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min. Beads were washed and recovered 3 times with 150 µl CSF-XB with 0.05% Triton 
X-100. Beads were resuspended in SDS-PAGE buffer and boiled. Control 
immunoprecipitation was performed using purified preimmune rabbit IgG (Sigma-
Aldrich). 
To test somatic CDCA7 and CDCA7L binding to HELLS, MYC-CDCA7, MYC-
CDCA7L, and MYC-CDCA7e mRNA were generated with an mMESSAGE mMACHINE 
SP6 kit (Life Technologies) according to manufacturer’s instructions. mRNA was added 
to interphase Xenopus egg extract (100 µg/ml final) and incubated for 90 min, prior to 
immunoprecipitation experiment as described previously. 
For immunoprecipitation of exogenously expressed Myc-CDCA7e and HELLS-
GFP, the indicated mRNAs were generated with an mMESSAGE mMACHINE SP6 kit 
(Life Technologies) according to manufacturer’s instructions. mRNA was added to 
interphase Xenopus egg extract (100 µg/ml final) and incubated for 90 min. 
Cycloheximide was added to stop translation (100 µg/mL), and half of the sample was 
cycled to M phase by addition of cyclin-B D90 (24 µg/mL) prior to immunoprecipitation 
experiment as described previously. 
Nucleosome assembly on plasmids 
pBlueScript plasmid was incubated in interphase or mitotic Xenopus extract (20 
ng/uL final) at 20 °C. At the indicated time points, 25 µL extract was removed and 
diluted 1:10 in Stop Buffer (20 mM Tris, 20 mM EDTA, 0.5% SDS, 0.05 mg/ml RNase A, 
pH 8.0 @ 22 °C) and incubated for 25 min at 37 °C. The solution was diluted 1:1 in Stop 
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Buffer supplemented with 1 mg/mL Proteinase K instead of RNase A and incubated for 
30 min at 37 °C. DNA was phenol-chloroform extract twice, chloroform extract once, 
and ethanol precipitated. DNA pellets were resuspended in TE (10 mM Tris, 1 mM 
EDTA, pH 8.0 @ 22 °C) containing 0.05 mg/mL RNase A, and incubated 37 °C for 15 
minutes. Samples were resolved on 1% agarose gel for 36 h at 0.75 V/cm. Gel was 
stained with SybrSafe (Thermo Fisher) and imaged. 
Chromosome and spindle assembly 
To assemble mitotic spindles, demembranated Xenopus sperm (1,000 sperm/µL 
extract) was replicated in interphase Xenopus egg extract for 90 min at 20 °C. To cycle 
the extract into mitosis, two volumes of fresh CSF extract and cycle B D90 (24 µg/mL) 
was added. Where indicated, nocodazole was added to 32 µM to depolymerize 
microtubules. The extract was mixed and incubated for 45-60 min at 20 °C. Extract (20 
µL) was diluted 1:100 in Spindle Fix (1X BRB80 (80 mM PIPES, 1 mM MgCl2, 1 mM
EGTA pH 6.9), 30% glycerol, 2% formaldehyde), mixed by inversion, and incubated for 
5 min at room temperature. The sample was layer on top of 5 mL Spindle Cushion (1X 
BRB80, 40% glycerol) and centrifuged onto a coverslip (Sorvall HB6, 5500 rpm, 18 °C 
for 15 min). The cushion interface was washed twice in 1X BRB80 and the cushion was 
removed by aspiration. The cover slip was removed and fixed in ice cold methanol (300 
µL) for 5 min. Spindles were visualized by processing the coverslips for 
immunofluorescence (above). 
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To assemble mitotic chromosomes, demembranated Xenopus sperm (1,000 
sperm/µL extract) was replicated in interphase Xenopus egg extract for 90 min at 20 °C. 
To cycle the extract into mitosis, two volumes of fresh CSF extract and cyclin B D90 (24 
µg/mL) was added. Where indicated, nocaodazole was added to 32 µM to depolymerize 
microtubules. The extract was mixed and incubated for 45-60 min at 20 °C. Extract was 
dilute 1:4 in Chromosome Dilution Buffer (10 mM HEPES, 250 mM Sucrose, 5mM 
EGTA, 200 mM KCl, 0.5 mM MgCl2, pH 8.0), and incubated 10 min at room 
temperature. Mixture was dilute 1:4 in Chromosome Fix (1X MMR (5 mM HEPES, 100 
mM NaCl, 2 mM KCl, 1mM MgCl2, 2 mM CaCl2, 0.1 mM EDTA, pH 7.8), 0.5% Triton X-
100, 20% glycerol, 2.664% formaldehyde) and incubated 5 min at room temperature. 
The sample was layer on top of X mL Chromosome Cushion (1X MMR, 40% glycerol) 
and centrifuged onto a coverslip (Sorvall HB6, 8000 rpm, 30min at 18°C). The cushion 
interface was washed twice in 1X BRB80 and the cushion was removed by aspiration. 
Chromosomes were visualized by processing the coverslips for immunofluorescence 
(above). 
DNA methylation assays 
To directly assay for DNA methylation, 1 µL 3H-SAM (Perkin Elmer, NET155H) 
was added to 50 µL interphase extract containing sperm chromatin (1000 sperm/µL) 
and incubated for 22 °C for 1 hr. The extract was diluted with 250 µL CPB (50 mM KCl, 
5 mM MgCl2, 20 mM HEPEK-KOH, 2% sucrose, pH 7.7), and mixed by flicking. Nuclei 
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were isolated with the Wizard Genomic DNA Purification Kit (Promega, A1120), and 3H 
incorporation was determined by scintillation counting. 
To indirectly assay for DNA methylation, Xenopus sperm (3000/µL) was added to 
interphase extract and incubated for 3 hr at 22 °C. Extract was diluted five-fold in CPB + 
0.1% NP-40, and layered onto a CPB-30% sucrose cushion. Chromatin was pelleted by 
centrifugation, 15,000g for 10 minutes. The sample-cushion interface was washed twice 
with TBS + 0.5% Triton X-100, and the cushion was removed. The chromatin pellet was 
recovered in 20 µL SDS-PAGE buffer, resolved by gel electrophoresis, and Western 
blotting was performed against the indicated proteins. Abrogation in DNA methylation 
results in the accumulation of H3-ubiquitylation, monitored by a slower migrating H3 
band. 
Kinetoplast DNA decatenation assay 
Kinetoplast DNA (Topogen) (10 ng/µL) was added to Xenopus egg extract, and 
the mixture was incubated on ice. At the indicated time, 15 µL extract was removed, 
diluted 1:10 in Stop Buffer (20 mM Tris, 20 mM EDTA, 0.5% SDS, 0.05 mg/ml RNase A, 
pH 8.0 @ 22 °C) and incubated for 25 min at 37 °C. The solution was diluted 1:1 in Stop 
Buffer supplemented with 1 mg/mL Proteinase K instead of RNase A and incubated for 
30 min at 37 °C. DNA was phenol-chloroform extract twice, chloroform extract once, 
and ethanol precipitated. DNA pellets were resuspended in TE (10 mM Tris, 1 mM 
EDTA, pH 8.0 @ 22 °C) containing 0.05 mg/mL RNase A, and incubated 37 °C for 15 
minutes. Samples were resolved on 1% agarose. Gel was stained with SybrSafe and 
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imaged. For the indicated experiments, nucleosomal kinetoplast chromatin was 
assembled by salt dialysis, and verified by MNase digestion. 
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CHAPTER 6: APPENDIX 
Figure A-1. Phylogeny of SNF2 family remodeling proteins. Rooted tree of SNF 
family proteins, taken from (Flaus et al., 2006). 
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Figure A-2. Alignment of CDCA7 (red) and CDCA7L (black) from the indicated 
species. 
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Figure A-3. Most abundant proteins binding mitotic naked DNA. Proteins with >10 
fold enrichment on naked DNA over nucleosome beads isolated from mitotic extract, 
quantified by mass spectrometry. 
Gene	
Symbol Protein
Abundance	on	
Nucleosomes
Abundance	on	
Naked	DNA
YBX2 Y-box-binding	protein	2	 n.d. 4.88 x	107
CL19415Contig1 Uncharacterized	Protein n.d. 3.36	x	107
FARSB Phenylalanine--tRNA	ligase	beta	
subunit	
n.d. 2.64 x	107
KARS Lysine--tRNA	ligase	 n.d. 2.57 x	107
AIMP1 Aminoacyl	tRNA	synthase	complex-
interacting	multifunctional	protein	1	
n.d. 2.46 x	107
KARS Lysine--tRNA	ligase	 n.d. 2.42 x	107
EPRS Bifunctional	glutamate/proline--tRNA	
ligase	
n.d. 2.32 x	107
DARS Aspartate--tRNA	ligase,	cytoplasmic	 n.d. 2.04 x	107
QARS Glutamine--tRNA	ligase	 n.d. 1.91 x	107
AIMP1 Aminoacyl	tRNA	synthase	complex-
interacting	multifunctional	protein	1	
n.d. 1.69 x	107
		177 
 
Figure A-4. Most abundant interphase proteins affected by nucleosomes. Proteins 
with >10 fold enrichment on nucleosome beads (top) or naked DNA beads (bottom) 
isolated from interphase extract, quantified by mass spectrometry 
 
Gene	
Symbol Protein
Abundance	on	
Naked	DNA
Abundance	on	
Nucleosomes
HIST1H4A Histone	H4	 2.07	x	1010 6.08 x	108
HIST2H2BF Histone	H2B	 1.91 x	1010 4.25 x	108
HIST2H3A Histone	H3.2	 1.40 x	1010 1.33 x	108
H2AFX Histone	H2A.x	 1.19 x	1010 3.58 x	108
HIST2H2AB Histone	H2A	type	2-B	 1.13 x	1010 3.58 x	108
H1FOO Histone	H1oo	 1.24 x	1010 7.22 x	107
AURKB Aurora	kinase	B	 8.01 x	109 1.43 x	107
H1FOO Histone	H1oo	 7.77 x	109 6.45 x	107
RCC1 Regulator	of	chromosome	condensation	 2.54 x	109 n.d.
SUPT16H FACT	complex	subunit	SPT16	 1.36 x	109 n.d.
RAN GTP-binding	nuclear	protein	Ran	 1.23 x	109 n.d.
SSRP1 FACT	complex	subunit	SSRP1	 8.30 x	108 n.d.
PI4KA Phosphatidylinositol	4-kinase	alpha	 n.d. 3.49 x	109
DARS Aspartate--tRNA	ligase,	cytoplasmic	 n.d. 1.77 x	109
HMGB2 High	mobility	group	protein	B2	 2.30 x	107 1.72 x	109
KARS Lysine--tRNA	ligase	 n.d. 1.32 x	109
AIMP1 Aminoacyl	tRNA	synthase	complex-interacting	
multifunctional	protein	1	
n.d. 1.23 x	109
EPRS Bifunctional	glutamate/proline--tRNA	ligase	 n.d. 1.03 x	109
QARS Glutamine--tRNA	ligase	 n.d. 8.44 x	108
FARSB Phenylalanine--tRNA	ligase	beta	subunit	 n.d. 7.25 x	108
IARS Isoleucine--tRNA	ligase,	cytoplasmic	 n.d. 7.12 x	108
LARS Leucine--tRNA	ligase,	cytoplasmic	 n.d. 7.04 x	108
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Figure A-5. Most abundant proteins affected by the cell cycle. Proteins with >10 
fold enrichment on either M phase (top) or interphase (bottom) chromatin, quantified by 
mass spectrometry. 
Gene	
Symbol Protein
Abundance	on	
Interphase
chromatin
Abundance	on	
Interphase	
Chromatin
TUBB4B Tubulin	beta 1.34	x	107 1.38	x	109 
TUBA1B Tubulin	alpha n.d. 1.02	x	109 
SPAG5 Sperm-associated	antigen	5	 n.d. 4.92	x	108 
KNSTRN Small	kinetochore-
associated	protein	
n.d. 3.56 x	108 
ACTG1 Actin,	cytoplasmic	2 5.76	x	107  2.94 x	108 
NCAPG Condensin	complex	subunit	
3	
n.d. 2.46 x	108 
SMC4 Structural	maintenance	of	
chromosomes	protein	4	
n.d. 2.32 x	108 
KIAA1524 CIP2A	 2.71	x	107 2.10 x	108 
NCAPD2 Condensin	complex	subunit	
1	
n.d. 2.10 x	108 
SMC2 Structural	maintenance	of	
chromosomes	protein	2	
n.d. 1.97 x	108 
DDX3X ATP-dependent	RNA	
helicase	DDX3X	
2.10	x	1010 n.d.
MCM5 DNA	replication	licensing	
factor	MCM5	
2.16	x	109 2.21 x	107
MCM3 MCM3	minichromosome
maintenance	deficient	3	
2.00	x	109 n.d.
MCM7 DNA	replication	licensing	
factor	MCM7	
1.78	x	109 n.d.
MCM4 DNA	replication	licensing	
factor	MCM4	
1.76	x	109 1.74	x	107
MCM2 DNA	replication	licensing	
factor	MCM2	
1.63	x	109 n.d.
MCM6 DNA	replication	licensing	
factor	MCM6	
1.33	x	109 1.08 x	107
HELLS Lymphoid-specific	helicase	 3.58	x	108 2.06 x	107
NUP214 Nuclear	pore	complex	
protein	Nup214	
2.53	x	108 n.d.
CDCA7 Cell	division	cycle-
associated	protein	7	
2.35	x	108 n.d.
	179 
Figure A-6. Most abundant proteins binding H3K9me3. Proteins with >10 fold 
enrichment on H3K9me3 nucleosome beads over H3 unmodified isolated from 
interphase CPC depleted extract, quantified by mass spectrometry. 
Gene	
Symbol Protein
Abundance	on	
H3K9me3	
chromatin
Abundance	on	
H3 unmodified
chromatin
EMC4 ER	membrane	protein	complex	subunit	4	 1.11 x	1010 n.d.
CHD3 Chromodomain-helicase-DNA-binding	protein	
3	
2.28	x	109 n.d.
CBX3 Chromobox	protein	homolog	3	 4.27 x	109 1.27 x	107
ATRX Transcriptional	regulator	ATRX	 3.69 x	109 n.d.
TATDN1 Putative	deoxyribonuclease	TATDN1	 3.47 x	109 n.d.
SUV39H1 Histone-lysine	N-methyltransferase	SUV39H1	 2.15 x	109 n.d.
ERBB2IP Protein	LAP2	 1.79 x	109 n.d.
RBPJ Recombining	binding	protein	suppressor	of	
hairless	
1.11 x	109 n.d.
CDCA8 Borealin	 6.30 x	108 n.d.
CBX5 Chromobox	homolog	5	(HP1	alpha	homolog,	
Drosophila),	isoform	CRA_a	
5.53 x	108 n.d.
FANCL E3	ubiquitin-protein	ligase	FANCL	 4.98 x	108 n.d.
ASAP3 Arf-GAP	with	SH3	domain,	ANK	repeat	and	PH	
domain-containing	protein	3	
4.97 x	108 n.d.
SUV39H2 Histone-lysine	N-methyltransferase	SUV39H2	 4.86 x	108 n.d.
IRS1 Insulin	receptor	substrate	1	 4.37 x	108 n.d.
ZNF850 Zinc	finger	protein	850	 4.24 x	108 n.d.
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Figure A-7. Most abundant proteins affected by the CPC. Proteins with >10 fold 
enrichment on CPC depleted (top) or mock depleted (bottom) nucleosome beads 
isolated from M phase extract, quantified by mass spectrometry. 
 
 
 
Gene	
Symbol Protein
Abundance	on	
CPC
chromatin
Abundance	on	
MOCK
chromatin
CDCA7 Cell	division	cycle-associated	protein	7	 4.62 x	108 n.d.
HELLS Lymphoid-specific	helicase	 4.62 x	108 2.06	x	107	
CHD1 Chromodomain-helicase-DNA-binding	protein	1	 1.89 x	108 n.d.
EIF2B3 Translation	initiation	factor	eIF-2B	subunit	gamma	 1.64 x	108 n.d.
CCDC39 Coiled-coil	domain-containing	protein	39	 1.43 x	108 n.d.
UBE3C Ubiquitin-protein	ligase	E3C	 1.42 x	108 n.d.
CUL9 Cullin-9	 1.32 x	108 n.d.
PLCH2 1-phosphatidylinositol	4,5-bisphosphate	
phosphodiesterase	eta-2	
1.01 x	108 n.d.
CDH23 Cadherin	23	isoform	B2	 9.49 x	107 n.d.
BAZ1A Bromodomain	adjacent	to	zinc	finger	domain	protein	1A	 6.59 x	107 n.d.
TUBB4B Tubulin	beta 4.16 x	107 1.38 x	109
TUBA1B Tubulin	alpha 2.20 x	107 1.02 x	109
CCNB2 Cyclin	B2 n.d. 1.81 x	109
CDCA8 Borealin	 n.d. 1.67 x	109
AURKB Aurora	kinase	B	 n.d. 1.27 x	109
ZFP161 Zinc	finger	protein	161	homolog	 n.d. 1.14 x	106
ZMYM4 Zinc	finger	MYM-type	protein	4	 n.d. 1.09 x	109
ENO1 Alpha-enolase	 9.50	x	106 1.01 x	109
GAPDH Glyceraldehyde-3-phosphate	dehydrogenase	 n.d. 9.89 x	108
INCENP Inner	centromere	protein	 n.d. 8.26 x	108
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Figure A-8. Most abundant proteins affected by H1. Proteins with >10 fold 
enrichment on H1 depleted (top) or mock depleted (bottom) nucleosome beads isolated 
from M phase extract, quantified by mass spectrometry. 
Gene	
Symbol Protein
Abundance	on	
H1 chromatin
Abundance	on	
MOCK chromatin
DOK6 Docking	protein	6	 4.65	x	1010 n.d.
C11ORF16 Uncharacterized	protein	C11orf16	 1.55 x	1010 n.d.
HIST2H2AB Histone	H2A	type	2-B	 1.22 x	1010 n.d.
H2AFX Histone	H2A.x	 1.07 x	1010 8.73 x	108
HIST2H2AB Histone	H2A	type	2-B	 1.06 x	1010 7.08 x	107
RPA3 Replication	protein	A	14	kDa	subunit	 3.21 x	109 6.13 x	107
MFN2 Mitofusin-2	 2.037 x	109 n.d.
WDR35 WD	repeat-containing	protein	35	 7.61 x	108 n.d.
DPPA2 Developmental	Pluripotency	Associated	2 6.28 x	108 1.50 x	107
EIF2S2 Eukaryotic	 translation	initiation	factor	2	
subunit	2	
3.41 x	108 n.d.
PRPF8 Pre-mRNA-processing-splicing	factor	8	 n.d. 2.41	x	1010
SUMO3 Small	ubiquitin-related	modifier	3	 n.d. 2.47 x	109
SUMO2 Small	ubiquitin-related	modifier	2	 n.d. 2.43 x	109
H1FOO Histone	H1oo	 2.38 x	109
TBL3 Transducin	beta-like	protein	3	 n.d. 1.61 x	109
DC015933 Uncharacterized	Protein n.d. 9.73 x	108
HMGB1 High	mobility	group	protein	B1	 4.41 x	108
DSP Desmoplakin	 n.d. 4.25 x	108
ACTB Actin,	cytoplasmic	1	 3.67 x	108
ANXA7 Annexin	A7	 n.d. 3.55 x	108
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Figure A-9.  Depletions associated with Figure 2-7.  Extract from the experiments 
associated with Figure 2-7 were analyzed by Western blotting for the indicated proteins 
to assess depletion level. 
U
nt
re
at
ed
 E
xt
ra
ct
Bead pulldown
INCENP
H3K9me3
MCM7
ΔCPCMock
H3
M I M I M I M
ΔCPCMock
K9me3
I
M
O
CK
Δ
B4  <- Input 1/2 Dilutions
	183 
Figure A-10. HELLS and CDCA7 bind mononucleosomes independently of each 
other in vitro. Coomassie stained gel of a pulldown of mononucleosome beads without 
linker DNA or naked DNA beads incubated with the indicated proteins. Uncoupled 
beads were used to control for non-specific binding. Note the strong non-specific 
binding of HELLS to the bead only control. 
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Figure A-11.  Hierarchical clustering of chromatin associated proteins. Each 
column is the abundance of the indicated protein detected on chromatin under a given 
condition.  Columns 1, 2, 3, 4 are H3 nucleosome chromatin and columns 5, 6, 7, 8 are 
H3K9me3 chromatin.  Columns 1, 3, 5, 7, are M phase extract and columns 2, 4, 6, 8 
are interphase extract.  Columns 1, 2, 5, 6 are mock depleted extract and columns 3, 4, 
7, 8 are CPC depleted extract.  
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